[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 435
1. Ansari SH, Irfan M, Farzana, Panjwani VK, Shamsi TS: In-vivo purging with the anti-CD20 antibody rituximab along with standard allogeneic peripheral blood stem cell transplantation (PBSCT) for relapsed childhood pre-B acute lymphoblastic leukaemia (ALL). J Coll Physicians Surg Pak; 2006 Jan;16(1):67-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] In-vivo purging with the anti-CD20 antibody rituximab along with standard allogeneic peripheral blood stem cell transplantation (PBSCT) for relapsed childhood pre-B acute lymphoblastic leukaemia (ALL).
  • He did not develop acute graft versus host disease (aGvHD) but localized chronic GvHD developed.

  • Genetic Alliance. consumer health - Transplantation.
  • Hazardous Substances Data Bank. RITUXIMAB .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16441995.001).
  • [ISSN] 1022-386X
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Pakistan
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 0 / Immunologic Factors; 4F4X42SYQ6 / Rituximab
  •  go-up   go-down


2. Podgornik H, Debeljak M, Zontar D, Cernelc P, Prestor VV, Jazbec J: RUNX1 amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to acute myelogenous leukemia. Cancer Genet Cytogenet; 2007 Oct 1;178(1):77-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] RUNX1 amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to acute myelogenous leukemia.
  • Amplification of RUNX1 (alias AML1) is a recurrent karyotypic abnormality in childhood acute lymphoblastic leukemia (ALL) that is generally associated with a poor outcome.
  • It does not occur with other primary chromosomal abnormalities in acute ALL.
  • AML1 amplification in acute myelogenous leukemia (AML) is a rare secondary event described mainly in therapy-related cases.
  • AML1 amplification was found in a 13-year-old patient with AML M4/M5 leukemia that occurred 5 years after she had been diagnosed with common B-cell ALL.
  • Conventional cytogenetic, fluorescent in situ hybridization (FISH), and polymerase chain reaction methods revealed no other chromosomal change expected to occur in a disease that we assumed to be a secondary leukemia.
  • [MeSH-major] Core Binding Factor Alpha 2 Subunit / genetics. Gene Expression Regulation, Neoplastic. Leukemia, B-Cell / genetics. Leukemia, B-Cell / pathology. Leukemia, Myeloid, Acute / genetics. Leukemia, Myeloid, Acute / pathology. Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics. Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology


3. Ceviz N, Kaynar H, Olgun H, Onbaş O, Misirligil Z: Pigeon breeder's lung in childhood: is family screening necessary? Pediatr Pulmonol; 2006 Mar;41(3):279-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pigeon breeder's lung in childhood: is family screening necessary?
  • In this paper, we report on clinical and laboratory findings of pigeon breeder's lung (PBL) in a mother and her 2 children: 2 with the chronic recurrent form, and 1 with the chronic insidious form without any symptoms or signs, who was diagnosed during family screening.
  • In conclusion, in patients with acute respiratory symptoms and rapidly recovering pulmonary hypertension after hospitalization, PBL should be remembered.

  • MedlinePlus Health Information. consumer health - Family Issues.
  • Hazardous Substances Data Bank. PREDNISOLONE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2006 Wiley-Liss, Inc.
  • (PMID = 16400661.001).
  • [ISSN] 8755-6863
  • [Journal-full-title] Pediatric pulmonology
  • [ISO-abbreviation] Pediatr. Pulmonol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 9PHQ9Y1OLM / Prednisolone
  •  go-up   go-down


Advertisement
4. Lee YY, Lin KL, Wang HS, Chou ML, Hung PC, Hsieh MY, Lin JJ, Wong AM: Craniocervical arterial dissection: a cause of childhood arterial ischemic stroke in Taiwan. J Formos Med Assoc; 2010 Feb;109(2):156-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Craniocervical arterial dissection: a cause of childhood arterial ischemic stroke in Taiwan.
  • BACKGROUND/PURPOSE: To describe the clinical characteristics and imaging findings of craniocervical dissection in childhood ischemic stroke, in a tertiary medical center.
  • One patient died at the acute stage and another seven had neurological deficits after 9 months to 8 years follow-up.
  • No patients had recurrent stroke.
  • CONCLUSION: Arterial dissection should be considered in childhood ischemic stroke.

  • Genetic Alliance. consumer health - Ischemic stroke.
  • MedlinePlus Health Information. consumer health - Ischemic Stroke.
  • MedlinePlus Health Information. consumer health - Stroke.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 Formosan Medical Association & Elsevier. Published by Elsevier B.V. All rights reserved.
  • (PMID = 20206840.001).
  • [ISSN] 0929-6646
  • [Journal-full-title] Journal of the Formosan Medical Association = Taiwan yi zhi
  • [ISO-abbreviation] J. Formos. Med. Assoc.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] Singapore
  •  go-up   go-down


5. Akyüz C, Yalçin B, Yildiz I, Hazar V, Yörük A, Tokuç G, Akici F, Büyükpamukçu N, Kale G, Atahan L, Büyükünal C, Dervişoğlu S, Atkovar GA, Melikoğlu M, Karpuzoğlu G, Olgun N, Ayan I, Oğuz A, Yariş N, Dağdemir A, Darendeliler E, Sander S, Kuyumcuoğlu U, Ozşeker N, Corapçioğlu F, Tanyeli A, Düzovali O, Aydin GB, Büyükpamukçu M: Treatment of Wilms tumor: a report from the Turkish Pediatric Oncology Group (TPOG). Pediatr Hematol Oncol; 2010 Apr;27(3):161-78
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment of Wilms tumor: a report from the Turkish Pediatric Oncology Group (TPOG).
  • AIM: To standardize diagnosis and treatment of childhood Wilms tumor (WT) in Turkey.
  • 1/11 cases with recurrent disease died; 2/165 had progressive disease, 2/165 had secondary cancers, and all 4 died.
  • CONCLUSIONS: Despite problems in patient management and follow-up, treatment results were encouraging in this first national experience with a multicentric study in pediatric oncology.


11. Golz A, Netzer A, Westerman ST, Westerman LM, Gilbert DA, Joachims HZ, Goldenberg D: Reading performance in children with otitis media. Otolaryngol Head Neck Surg; 2005 Mar;132(3):495-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To examine whether middle ear diseases and the associated hearing loss in early childhood affect reading performance later at school.
  • STUDY DESIGN AND SETTING: One hundred and sixty children, 6.5 to 8 years of age, were enrolled in this study: 80 children with a history of recurrent infections and/or prolonged periods of effusions of the middle ear before the age of 5 years, and 80 healthy children without any history of middle ear disease.
  • CONCLUSION: Children with recurrent or prolonged middle ear diseases during the first five years of life tend to be at greater risk for delayed reading than aged-matched controls with no previous middle ear diseases.

  • MedlinePlus Health Information. consumer health - Ear Infections.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15746869.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Ebo DG, Verweij MM, De Knop KJ, Hagendorens MM, Bridts CH, De Clerck LS, Stevens WJ: Hereditary angioedema in childhood: an approach to management. Paediatr Drugs; 2010 Aug 01;12(4):257-68
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hereditary angioedema in childhood: an approach to management.
  • Hereditary angioedema (HAE) is an inherited disorder characterized by recurrent, circumscribed, non-pitting, non-pruritic, and rather painful subepithelial swelling of sudden onset, which fades during the course of 48-72 hours, but can persist for up to 1 week.
  • The diagnosis of HAE is suggested by a positive family history, the absence of accompanying pruritus or urticaria, the presence of recurrent gastrointestinal attacks of colic, and episodes of laryngeal edema.
  • Plasma-derived C1-inhibitor concentrate, recombinant C1-inhibitor, ecallantide (DX88; a plasma kallikrein inhibitor) and icatibant (a bradykinin B(2) receptor antagonist) have demonstrated significant efficacy in the treatment of acute attacks, whereas the C1-inhibitor concentrate has also provided a significant benefit as long-term prophylaxis.

  • Genetic Alliance. consumer health - Hereditary angioedema.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Med. 1990 Jun;88(6):656-64 [2189311.001]
  • [Cites] Br J Pharmacol. 1987 Dec;92(4):851-5 [3427282.001]
  • [Cites] Annu Rev Immunol. 1988;6:595-628 [3289579.001]
  • [Cites] Proc Assoc Am Physicians. 1997 Mar;109(2):164-73 [9069585.001]
  • [Cites] Curr Opin Pediatr. 2005 Dec;17(6):686-9 [16282771.001]
  • [Cites] J Allergy Clin Immunol. 1995 Aug;96(2):259-61 [7636064.001]
  • [Cites] Allergy. 2004 May;59(5):557-8 [15080842.001]
  • [Cites] J Allergy Clin Immunol. 1983 Sep;72(3):294-8 [6886261.001]
  • [Cites] J Allergy Clin Immunol. 2000 Dec;106(6):1147-54 [11112899.001]
  • [Cites] Cytogenet Genome Res. 2008;121(3-4):181-8 [18758157.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Nov;96(5):540-3 [14600687.001]
  • [Cites] Pediatr Res. 1979 Sep;13(9):1043-6 [503656.001]
  • [Cites] J Allergy Clin Immunol. 1975 Jun;55(6):386-93 [1138015.001]
  • [Cites] Allergy. 2007 Aug;62(8):842-56 [17620062.001]
  • [Cites] J Allergy Clin Immunol. 2006 Apr;117(4):904-8 [16630950.001]
  • [Cites] J Intern Med. 1997 Jan;241(1):39-46 [9042092.001]
  • [Cites] N Engl J Med. 1972 Apr 13;286(15):808-12 [4551861.001]
  • [Cites] J Am Dent Assoc. 2003 Aug;134(8):1088-94 [12956349.001]
  • [Cites] J Clin Invest. 1973 Jun;52(6):1402-9 [4703226.001]
  • [Cites] Immunol Allergy Clin North Am. 2006 Nov;26(4):653-68 [17085283.001]
  • [Cites] N Engl J Med. 1996 Jun 20;334(25):1630-4 [8628358.001]
  • [Cites] N Engl J Med. 1980 Aug 28;303(9):526-7 [7393306.001]
  • [Cites] Clin Exp Immunol. 1996 Dec;106(3):475-80 [8973615.001]
  • [Cites] J Allergy Clin Immunol. 2005 Oct;116(4):876-83 [16210064.001]
  • [Cites] Ann Allergy Asthma Immunol. 2007 Apr;98(4):383-8 [17458436.001]
  • [Cites] Med Interne. 1989 Apr-Jun;27(2):143-7 [2814292.001]
  • [Cites] J Oral Pathol Med. 1991 Mar;20(3):139-42 [1828083.001]
  • [Cites] Am J Hum Genet. 1996 Aug;59(2):308-19 [8755917.001]
  • [Cites] Am J Med Sci. 1982 Jul-Aug;284(1):2-9 [7091182.001]
  • [Cites] Br J Dermatol. 2006 Mar;154(3):542-5 [16445789.001]
  • [Cites] Lancet. 1999 Mar 27;353(9158):1066-7 [10199359.001]
  • [Cites] Hum Mutat. 2005 Jan;25(1):1-5 [15580551.001]
  • [Cites] Eur J Emerg Med. 2000 Jun;7(2):111-2 [11132070.001]
  • [Cites] Transfusion. 2005 Nov;45(11):1774-84 [16271103.001]
  • [Cites] J Allergy Clin Immunol. 1986 May;77(5):749-57 [3084606.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2001 Oct;13(10 ):1225-30 [11711780.001]
  • [Cites] Expert Opin Investig Drugs. 2006 Sep;15(9):1077-90 [16916274.001]
  • [Cites] Pediatr Allergy Immunol. 2005 Jun;16(4):288-94 [15943590.001]
  • [Cites] J Emerg Med. 2007 Aug;33(2):137-9 [17692764.001]
  • [Cites] J Clin Pathol. 2004 Feb;57(2):213-4 [14747456.001]
  • [Cites] Blood. 1997 May 1;89(9):3213-8 [9129025.001]
  • [Cites] N Engl J Med. 1972 Aug 31;287(9):452-4 [4558045.001]
  • [Cites] Transfus Apher Sci. 2003 Dec;29(3):255-8 [14572818.001]
  • [Cites] Pediatrics. 1966 Jun;37(6):1017-27 [5327109.001]
  • [Cites] Am J Dis Child. 1981 Oct;135(10):918-20 [6975036.001]
  • [Cites] Ann Allergy Asthma Immunol. 2005 Apr;94(4):498-503 [15875532.001]
  • [Cites] Acta Med Scand. 1977;201(5):415-27 [899863.001]
  • [Cites] Clin Exp Immunol. 2007 Sep;149(3):513-6 [17614974.001]
  • [Cites] Transfusion. 1998 Jun;38(6):540-9 [9661687.001]
  • [Cites] Pediatrics. 2007 Sep;120(3):e713-22 [17724112.001]
  • [Cites] Mol Immunol. 2007 Feb;44(6):1454-60 [16750855.001]
  • [Cites] Ann Allergy Asthma Immunol. 1998 Jun;80(6):457-61 [9647267.001]
  • [Cites] Lancet. 1969 Feb 15;1(7590):326-30 [4179348.001]
  • [Cites] J Allergy Clin Immunol. 1979 Oct;64(4):275-80 [479480.001]
  • [Cites] Curr Opin Pediatr. 2008 Aug;20(4):425-30 [18622198.001]
  • [Cites] Acta Clin Belg. 2009 Nov-Dec;64(6):520-8 [20101876.001]
  • [Cites] J Clin Ultrasound. 1999 Nov-Dec;27(9):537-40 [10525217.001]
  • [Cites] J Allergy Clin Immunol. 2008 Feb;121(2 Suppl):S398-401; quiz S419 [18241690.001]
  • [Cites] Lancet. 2000 Jul 15;356(9225):213-7 [10963200.001]
  • [Cites] Am J Hum Genet. 2006 Dec;79(6):1098-104 [17186468.001]
  • [Cites] Am J Emerg Med. 2004 Nov;22(7):633 [15666287.001]
  • [Cites] J Clin Invest. 2002 Apr;109(8):1057-63 [11956243.001]
  • [Cites] Biochem Biophys Res Commun. 2006 May 19;343(4):1286-9 [16638441.001]
  • [Cites] N Engl J Med. 2008 Sep 4;359(10):1027-36 [18768946.001]
  • [Cites] Curr Opin Investig Drugs. 2008 Mar;9(3):310-23 [18311668.001]
  • [Cites] J Clin Invest. 1983 Apr;71(4):1041-6 [6833491.001]
  • [Cites] Clin Ther. 2001 Sep;23(9):1355-90 [11589254.001]
  • [Cites] Medicine (Baltimore). 1992 Jul;71(4):206-15 [1518394.001]
  • [Cites] Immunol Allergy Clin North Am. 2006 Nov;26(4):633-51 [17085282.001]
  • [Cites] Ann Allergy Asthma Immunol. 2008 Sep;101(3):279-86 [18814451.001]
  • [Cites] Genet Med. 2006 Apr;8(4):249-54 [16617246.001]
  • [Cites] Transfus Apher Sci. 2003 Dec;29(3):247-54 [14572817.001]
  • [Cites] Pediatr Res. 1994 Feb;35(2):184-7 [8165053.001]
  • [Cites] N Engl J Med. 1980 Aug 28;303(9):527 [7393307.001]
  • [Cites] J Clin Pathol. 2002 Feb;55(2):145-7 [11865013.001]
  • [Cites] J Allergy Clin Immunol. 2005 Apr;115(4):864-9 [15806011.001]
  • [Cites] J Hepatol. 2002 May;36(5):707-9 [11983460.001]
  • [Cites] Scand J Immunol. 1996 Aug;44(2):185-92 [8711433.001]
  • [Cites] AJR Am J Roentgenol. 2001 Mar;176(3):649-52 [11222198.001]
  • [Cites] Am J Gastroenterol. 2006 Mar;101(3):619-27 [16464219.001]
  • [Cites] Am J Med. 1999 Jun;106(6):650-4 [10378623.001]
  • [Cites] J Allergy Clin Immunol. 1987 Dec;80(6):855-60 [3693762.001]
  • [Cites] Arch Pediatr. 2008 Mar;15(3):271-4 [18329867.001]
  • [Cites] Mol Immunol. 2008 Aug;45(13):3536-44 [18586324.001]
  • [Cites] J Allergy Clin Immunol. 1997 Feb;99(2):194-6 [9042044.001]
  • [Cites] Nature. 1986 Oct 23-29;323(6090):722-4 [3534579.001]
  • [Cites] Ann Intern Med. 1976 May;84(5):580-93 [1275365.001]
  • [Cites] Eur Ann Allergy Clin Immunol. 2008 May;40(1):5-13 [18700329.001]
  • [Cites] Glycobiology. 2004 Jan;14(1):51-64 [14514717.001]
  • [Cites] Mol Immunol. 2001 Aug;38(2-3):161-73 [11532278.001]
  • [Cites] CMAJ. 2006 Oct 24;175(9):1065-70 [17060655.001]
  • [Cites] Naunyn Schmiedebergs Arch Pharmacol. 1987 Oct;336(4):430-3 [2893297.001]
  • [Cites] Arch Intern Med. 2001 Nov 12;161(20):2417-29 [11700154.001]
  • [Cites] N Engl J Med. 1987 May 28;316(22):1360-6 [3494945.001]
  • [Cites] Ann Allergy Asthma Immunol. 2004 Mar;92(3):377-8 [15049404.001]
  • [Cites] Immunol Allergy Clin North Am. 2006 Nov;26(4):725-37 [17085287.001]
  • [Cites] JAMA. 1982 Apr 9;247(14):2005-7 [6174746.001]
  • [Cites] Am J Med. 1963 Jul;35:37-44 [14046003.001]
  • [Cites] Immunol Lett. 2003 May 1;86(3):271-6 [12706530.001]
  • [Cites] Clin Chem. 1988 Aug;34(8):1618-21 [3261214.001]
  • [Cites] N Engl J Med. 1976 Dec 23;295(26):1444-8 [792688.001]
  • [Cites] J Allergy Clin Immunol. 2007 Sep;120(3):654-8 [17765757.001]
  • [Cites] J Allergy Clin Immunol. 2007 Oct;120(4):941-7 [17761272.001]
  • [Cites] Arch Intern Med. 2001 Mar 12;161(5):714-8 [11231704.001]
  • [Cites] N Engl J Med. 1980 Mar 6;302(10):542-6 [7351888.001]
  • [Cites] Ann Allergy Asthma Immunol. 2008 Jan;100(1 Suppl 2):S7-12 [18220146.001]
  • [Cites] Ann Allergy Asthma Immunol. 2008 Jan;100(1 Suppl 2):S30-40 [18220150.001]
  • [Cites] Endocrinology. 1995 Nov;136(11):5076-83 [7588244.001]
  • [Cites] Clin Exp Immunol. 2007 Jan;147(1):11-7 [17177958.001]
  • [Cites] Medicine (Baltimore). 2003 Jul;82(4):274-81 [12861105.001]
  • [Cites] J Clin Invest. 1984 May;73(5):1249-53 [6371055.001]
  • [Cites] J Allergy Clin Immunol. 2004 Sep;114(3 Suppl):S51-131 [15356535.001]
  • [Cites] Mayo Clin Proc. 1980 Apr;55(4):277-8 [7359956.001]
  • [Cites] Clin Rev Allergy Immunol. 2008 Apr;34(2):250-9 [18330729.001]
  • [Cites] J Allergy Clin Immunol. 2000 Sep;106(3):546-50 [10984376.001]
  • [Cites] Immunobiology. 2007;212(4-5):325-31 [17544817.001]
  • [Cites] Am J Med. 2006 Mar;119(3):267-74 [16490473.001]
  • [Cites] J Lab Clin Med. 1996 Feb;127(2):229-32 [8636653.001]
  • [Cites] J Allergy Clin Immunol. 1981 Sep;68(3):181-7 [6790595.001]
  • (PMID = 20593909.001).
  • [ISSN] 1179-2019
  • [Journal-full-title] Paediatric drugs
  • [ISO-abbreviation] Paediatr Drugs
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  •  go-up   go-down


13. Falsafi T, Valizadeh N, Sepehr S, Najafi M: Application of a stool antigen test to evaluate the incidence of Helicobacter pylori infection in children and adolescents from Tehran, Iran. Clin Diagn Lab Immunol; 2005 Sep;12(9):1094-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Helicobacter pylori infection is acquired mainly in childhood, especially in developing countries, where a low-cost, rapid diagnostic technique which is reliable for all age groups may be useful for the management of H. pylori infection.
  • A questionnaire that included presence of recurrent abdominal pain (RAP), family history of infection and/or peptic ulcer disease (PUD), and income of parents was completed.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • International Agency for Research on Cancer - Screening Group. diagnostics - Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pediatrics. 2000 Jul;106(1 Pt 1):115-7 [10878159.001]
  • [Cites] Rev Gastroenterol Disord. 2004 Winter;4(1):1-6 [15029105.001]
  • [Cites] World J Gastroenterol. 2004 Mar 15;10(6):913-4 [15040045.001]
  • [Cites] J Gastroenterol Hepatol. 2004 May;19(5):490-6 [15086591.001]
  • [Cites] Pediatrics. 1995 Aug;96(2 Pt 1):211-5 [7630671.001]
  • [Cites] Arch Pediatr. 1996 Apr;3(4):329-34 [8762953.001]
  • [Cites] Acta Paediatr. 1999 Jun;88(6):598-601 [10419241.001]
  • [Cites] Pediatrics. 2005 Jan;115(1):17-21 [15629976.001]
  • [Cites] Scott Med J. 2004 Nov;49(4):136-8 [15648706.001]
  • [Cites] J Pediatr. 2005 Feb;146(2):198-203 [15689908.001]
  • [Cites] Eur J Gastroenterol Hepatol. 1999 Oct;11(10):1139-42 [10524644.001]
  • [Cites] J Pak Med Assoc. 1999 May;49(5):112-4 [10555426.001]
  • [Cites] J Clin Microbiol. 2000 Oct;38(10):3710-4 [11015388.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2000 Oct;31(4):405-10 [11045838.001]
  • [Cites] J Clin Pathol. 2000 Oct;53(10):756-9 [11064668.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2000 Oct;19(10):787-9 [11117645.001]
  • [Cites] Aliment Pharmacol Ther. 2001 Feb;15(2):203-6 [11148438.001]
  • [Cites] J Clin Microbiol. 2001 Apr;39(4):1348-52 [11283055.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2001 Sep;13(9):1047-52 [11564953.001]
  • [Cites] Helicobacter. 2001 Sep;6(3):234-8 [11683926.001]
  • [Cites] J Pediatr. 2001 Nov;139(5):734-7 [11713455.001]
  • [Cites] Dig Dis Sci. 2001 Nov;46(11):2440-4 [11713949.001]
  • [Cites] Acta Paediatr Taiwan. 2001 Sep-Oct;42(5):278-81 [11729703.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2001 Nov;33(5):558-64 [11740229.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2002 Mar;34(3):281-5 [11964952.001]
  • [Cites] Am J Gastroenterol. 2002 Nov;97(11):2756-62 [12425544.001]
  • [Cites] J Gastroenterol Hepatol. 2003 Jan;18(1):26-31 [12519220.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2003 Feb;15(2):179-83 [12560763.001]
  • [Cites] Am J Gastroenterol. 2003 Feb;98(2):296-300 [12591044.001]
  • [Cites] J Gastroenterol. 2003;38(3):222-8 [12673444.001]
  • [Cites] Gut. 2003 Jun;52(6):804-6 [12740334.001]
  • [Cites] J Clin Microbiol. 2003 Jul;41(7):3334-5 [12843086.001]
  • [Cites] J Clin Pathol. 2003 Oct;56(10):769-71 [14514781.001]
  • [Cites] Helicobacter. 2003;8 Suppl 1:8-12 [14617212.001]
  • [Cites] Helicobacter. 2003;8 Suppl 1:61-7 [14617219.001]
  • [Cites] J Clin Microbiol. 2004 Jan;42(1):387-9 [14715786.001]
  • [Cites] J Clin Microbiol. 2004 Mar;42(3):1319-21 [15004108.001]
  • [Cites] Am J Gastroenterol. 2000 Sep;95(9):2200-5 [11007218.001]
  • (PMID = 16148176.001).
  • [ISSN] 1071-412X
  • [Journal-full-title] Clinical and diagnostic laboratory immunology
  • [ISO-abbreviation] Clin. Diagn. Lab. Immunol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Randomized Controlled Trial
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Bacterial
  • [Other-IDs] NLM/ PMC1235796
  •  go-up   go-down


14. Sedivá A, Smith CI, Asplund AC, Hadac J, Janda A, Zeman J, Hansíková H, Dvoráková L, Mrázová L, Velbri S, Koehler C, Roesch K, Sullivan KE, Futatani T, Ochs HD: Contiguous X-chromosome deletion syndrome encompassing the BTK, TIMM8A, TAF7L, and DRP2 genes. J Clin Immunol; 2007 Nov;27(6):640-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • X-linked agammaglobulinemia (XLA) is characterized by low levels of B-lymphocytes with early-onset, recurrent, microbial infections occasionally causing neurological symptoms.
  • We observed an atypical clinical course of XLA, complicated since early childhood with neurological impairment, progressive sensorineural deafness, and dystonia in six boys of four unrelated families.

  • Genetics Home Reference. consumer health - BTK gene.
  • Genetics Home Reference. consumer health - TIMM8A gene.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Mol Genet. 2004 Sep 15;13(18):2101-11 [15254020.001]
  • [Cites] Immunol Rev. 2005 Feb;203:200-15 [15661031.001]
  • [Cites] Genomics. 1999 Nov 1;61(3):259-67 [10552927.001]
  • [Cites] J Immunol. 1994 Jan 15;152(2):557-65 [8283037.001]
  • [Cites] J Pediatr. 1994 Feb;124(2):224-8 [8301427.001]
  • [Cites] Methods Enzymol. 1992;215:42-58 [1435338.001]
  • [Cites] Nature. 1993 Jan 21;361(6409):226-33 [8380905.001]
  • [Cites] Clin Immunol. 1999 Dec;93(3):190-7 [10600329.001]
  • [Cites] J Med Genet. 1995 Apr;32(4):257-63 [7643352.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2141-6 [10051608.001]
  • [Cites] Cell. 1993 Jan 29;72(2):279-90 [8425221.001]
  • [Cites] Acta Genet Stat Med. 1960;10:54-62 [13771732.001]
  • [Cites] Pediatrics. 1952 Jun;9(6):722-8 [14929630.001]
  • [Cites] Brain. 2003 Aug;126(Pt 8):1814-20 [12805099.001]
  • [Cites] Hum Mol Genet. 1995 Jan;4(1):51-8 [7711734.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1817-9 [10051550.001]
  • [Cites] Mol Cell Biol. 2007 Apr;27(7):2582-9 [17242199.001]
  • [Cites] Nat Genet. 1996 Oct;14(2):177-80 [8841189.001]
  • [Cites] Arch Neurol. 2001 Jun;58(6):1004-7 [11405816.001]
  • [Cites] Eur J Pediatr. 2008 Mar;167(3):317-21 [17520285.001]
  • [Cites] Pediatr Allergy Immunol. 2001 Apr;12(2):107-11 [11338284.001]
  • [Cites] Am J Med Genet. 1996 Jul 12;64(1):31-4 [8826445.001]
  • [Cites] Adv Otorhinolaryngol. 2000;56:176-80 [10868232.001]
  • [Cites] Nucleic Acids Res. 1995 Mar 25;23(6):1087-8 [7731798.001]
  • [Cites] J Pediatr. 1999 May;134(5):589-96 [10228295.001]
  • [Cites] Genomics. 1994 Jun;21(3):517-24 [7959728.001]
  • [Cites] J Cell Sci. 2003 May 1;116(Pt 9):1847-58 [12665565.001]
  • [Cites] Am J Med Genet. 1992 Apr 15-May 1;43(1-2):498-504 [1605232.001]
  • [Cites] Medicine (Baltimore). 1996 Nov;75(6):287-99 [8982147.001]
  • [Cites] Hum Mol Genet. 2002 Mar 1;11(5):477-86 [11875042.001]
  • [Cites] Eur J Hum Genet. 2000 Jun;8(6):464-7 [10878669.001]
  • [Cites] Arch Biochem Biophys. 1968 Jul;126(1):75-82 [4970348.001]
  • [Cites] BMC Genomics. 2007 Jan 17;8:19 [17233888.001]
  • [Cites] Hum Mutat. 2006 Dec;27(12):1209-17 [16969761.001]
  • (PMID = 17851739.001).
  • [ISSN] 0271-9142
  • [Journal-full-title] Journal of clinical immunology
  • [ISO-abbreviation] J. Clin. Immunol.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / HD17427
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Intercellular Signaling Peptides and Proteins; 0 / Membrane Transport Proteins; 0 / Nerve Tissue Proteins; 0 / TAF7 protein, human; 0 / TATA-Binding Protein Associated Factors; 0 / TIMM8A protein, human; 0 / Transcription Factor TFIID; 0 / collapsin response mediator protein-2; EC 2.7.10.1 / Agammaglobulinaemia tyrosine kinase; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.7.- / RNA Polymerase II
  •  go-up   go-down


15. Roelandt PR, Blockmans D: Common variable immunodeficiency (CVID): case report and review of the literature. Acta Clin Belg; 2009 Jul-Aug;64(4):355-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CVID has an estimated incidence of 1:10,000 to 1:200,000 (male:female 1:1) and usually presents in the second and third decade, although it also has a peak of incidence in childhood.
  • Since different organ systems can be affected, all clinicians need to be aware of this entity, especially when confronted with patients with recurrent infections and/or multiple autoimmune diseases.

  • Genetic Alliance. consumer health - Common Variable Immunodeficiency.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19810426.001).
  • [ISSN] 1784-3286
  • [Journal-full-title] Acta clinica Belgica
  • [ISO-abbreviation] Acta Clin Belg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  • [Chemical-registry-number] 0 / Antibodies, Anti-Idiotypic; 0 / Immunoglobulins
  •  go-up   go-down


16. Mishra A, Pant N, Chadha R, Choudhury SR: Choledochal cysts in infancy and childhood. Indian J Pediatr; 2007 Oct;74(10):937-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Choledochal cysts in infancy and childhood.
  • Eleven cases were 1 year or less in age (infantile group) and 30 patients were more than 1 year old (classical pediatric group).
  • CONCLUSION: Infants with CC constitute a distinct group with regard to clinical presentation and the pathological should be kept in mind while evaluating neonates and infants with cholestatic jaundice and older children with recurrent abdominal pain.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17978454.001).
  • [ISSN] 0973-7693
  • [Journal-full-title] Indian journal of pediatrics
  • [ISO-abbreviation] Indian J Pediatr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  •  go-up   go-down


17. Karrman K, Andersson A, Björgvinsdóttir H, Strömbeck B, Lassen C, Olofsson T, Nguyen-Khac F, Berger R, Bernard O, Fioretos T, Johansson B: Deregulation of cyclin D2 by juxtaposition with T-cell receptor alpha/delta locus in t(12;14)(p13;q11)-positive childhood T-cell acute lymphoblastic leukemia. Eur J Haematol; 2006 Jul;77(1):27-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Deregulation of cyclin D2 by juxtaposition with T-cell receptor alpha/delta locus in t(12;14)(p13;q11)-positive childhood T-cell acute lymphoblastic leukemia.
  • OBJECTIVES: The t(12;14)(p13;q11)--a recurrent translocation in childhood T-cell acute lymphoblastic leukemia (T-ALL)--has very recently been molecularly characterized in one case, which displayed overexpression of the cyclin D2 gene (CCND2).
  • PATIENTS AND METHODS: We have characterized two pediatric t(12;14)-positive T-ALLs using fluorescence in situ hybridization (FISH), cDNA microarray, and real-time polymerase chain reaction (PCR).
  • CONCLUSION: We have confirmed, in two additional cases, that the recurrent T-ALL-associated t(12;14) results in overexpression of cyclin D2.
  • [MeSH-major] Cyclins / genetics. Gene Expression Regulation, Neoplastic. Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics. Receptors, Antigen, T-Cell, alpha-beta / genetics. Receptors, Antigen, T-Cell, gamma-delta / genetics. Translocation, Genetic

  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia.
  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia, Childhood.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16548914.001).
  • [ISSN] 0902-4441
  • [Journal-full-title] European journal of haematology
  • [ISO-abbreviation] Eur. J. Haematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / CCND2 protein, human; 0 / Cyclin D2; 0 / Cyclins; 0 / Receptors, Antigen, T-Cell, alpha-beta; 0 / Receptors, Antigen, T-Cell, gamma-delta
  •  go-up   go-down


18. Styczynski J, Gil L, Derwich K, Wachowiak J, Balwierz W, Badowska W, Krawczuk-Rybak M, Matysiak M, Wieczorek M, Balcerska A, Sonta-Jakimczyk D, Stefaniak J, Kowalczyk J, Urasinski T, Sobol G, Komarnicki M, Wysocki M: Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study. Anticancer Res; 2009 May;29(5):1643-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study.
  • The aim of the study was the analysis of ex vivo activity of clofarabine and 14 other anticancer drugs in pediatric and adult acute lymphoblastic (ALL) and myeloid (AML) leukemia.
  • PATIENTS AND METHODS: The ex vivo drug resistance profile was analyzed in 282 patients, including 201 children with ALL de novo, 24 children with relapsed ALL, 25 children with AML de novo and 32 adults with AML.
  • Its activity in acute myeloid leukemia was independent of patient age.
  • No significant differences in drug resistance to clofarabine between pediatric age-based subgroups of ALL were detected, while it was observed for most of other drugs.
  • An activity of clofarabine in relapsed pediatric ALL patients was as good as in newly-diagnosed ones.
  • CONCLUSION: In comparison to childhood acute lymphoblastic leukemia, lack of differences in ex vivo activity gives rationale for use of clofarabine in refractory and relapsed pediatric and adult patients with acute myeloid leukemia.
  • [MeSH-major] Adenine Nucleotides / therapeutic use. Antineoplastic Agents / therapeutic use. Arabinonucleosides / therapeutic use. Leukemia / drug therapy
  • [MeSH-minor] Acute Disease. Adolescent. Adult. Child. Child, Preschool. Humans. Infant. Middle Aged. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Childhood Leukemia.
  • MedlinePlus Health Information. consumer health - Leukemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19443380.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Adenine Nucleotides; 0 / Antineoplastic Agents; 0 / Arabinonucleosides; 762RDY0Y2H / clofarabine
  •  go-up   go-down


19. Acar B, Inci Arikan F, Emeksiz S, Dallar Y: Risk factors for nephrolithiasis in children. World J Urol; 2008 Dec;26(6):627-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The aim of this study is to evaluate the clinical outcome in children with urinary calculi, to detect risk factors for nephrolithiasis in childhood.
  • MATERIAL AND METHODS: This retrospective study comprised 62 pediatric nephrolithiasis patients who have come for routine follow-up visits between the dates of January 2002-August 2006 (48% girls and 52% boys).
  • A positive correlation was found between recurrent urinary tract infection (UTI) and hypercalciuria (r = 0.528, P = 0.017).
  • Urinary citrate excretion showed a negative correlation with recurrent UTI (r = -0.503, P = 0.024).

  • MedlinePlus Health Information. consumer health - Kidney Stones.
  • Hazardous Substances Data Bank. CITRIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pediatr (Rio J). 2001 Mar-Apr;77(2):101-4 [14647599.001]
  • [Cites] Pediatr Nephrol. 2005 Jan;20(1):19-24 [15602663.001]
  • [Cites] Pediatr Nephrol. 2004 May;19(5):516-20 [15015063.001]
  • [Cites] Arq Bras Endocrinol Metabol. 2006 Aug;50(4):823-31 [17117307.001]
  • [Cites] Pediatr Nephrol. 2005 Oct;20(10):1435-8 [16047226.001]
  • [Cites] Pediatr Nephrol. 2007 Sep;22(9):1291-5 [17541648.001]
  • [Cites] Scand J Urol Nephrol. 2003;37(2):129-33 [12745721.001]
  • [Cites] Pediatr Rev. 2004 Apr;25(4):131-9 [15060181.001]
  • [Cites] Clin Nephrol. 2005 Mar;63(3):188-92 [15786819.001]
  • [Cites] Pediatr Nephrol. 2005 Nov;20(11):1587-92 [16133066.001]
  • [Cites] J Urol. 1998 Feb;159(2):374-8; discussion 378-9 [9649242.001]
  • [Cites] J Am Soc Nephrol. 2001 Sep;12(9):1986-93 [11518794.001]
  • (PMID = 18810456.001).
  • [ISSN] 0724-4983
  • [Journal-full-title] World journal of urology
  • [ISO-abbreviation] World J Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 2968PHW8QP / Citric Acid
  •  go-up   go-down


20. Wennick A, Hallström I: Swedish families' lived experience when a child is first diagnosed as having insulin-dependent diabetes mellitus: An ongoing learning process. J Fam Nurs; 2006 Nov;12(4):368-89
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sweden has the second highest nationwide incidence of childhood diabetes in Europe, and it is rapidly increasing.
  • The learning process was experienced as a recurrent phenomenon when the family was exposed to new situations or contexts.


21. Schaad UB: OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr; 2010 Feb;6(1):5-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review.
  • BACKGROUND: This study was conducted to assess the efficacy of OM-85 BV (Broncho-Vaxom) in the prevention of pediatric recurrent respiratory tract infections (RTIs).
  • Available evidence suggests that defining recurrent RTIs as >or=3 infections per fall-winter semester is both medically and epidemiologically justified.
  • Of the patients in the OM-85 BV treated population (n=435), 32% had recurrent RTIs (that is, >or=3 RTIs/6 months) vs. 58.2% in the placebo treated population (n=416; P<0.001).
  • CONCLUSIONS: This meta-analysis shows, as observed in several individual trials, that the population treated with OM-85 BV had significantly and consistently fewer cases of recurrent RTIs.
  • The data suggest that the effect is greater in patients at increased risk of recurrent RTIs.

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • PubMed Health. DARE review .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Microbiol. 1996 Dec;34(12):3007-11 [8940439.001]
  • [Cites] Allergol Immunopathol (Madr). 1998 Jan-Feb;26(1):17-22 [9585823.001]
  • [Cites] Chest. 2001 Jun;119(6):1742-8 [11399700.001]
  • [Cites] Bol Med Hosp Infant Mex. 1991 Jun;48(6):385-97 [1910553.001]
  • [Cites] Chest. 2002 Dec;122(6):2042-9 [12475845.001]
  • [Cites] Pediatr Infect Dis J. 1993 Aug;12(8):648-52 [8414777.001]
  • [Cites] Int J Immunopharmacol. 1984;6(2):111-7 [6234240.001]
  • [Cites] Helv Paediatr Acta. 1986 May;41(1-2):7-17 [3755127.001]
  • [Cites] PLoS Med. 2007 Jun;4(6):e184 [17550302.001]
  • [Cites] Rev Alerg Mex. 2005 Jan-Feb;52(1):25-38 [15957470.001]
  • [Cites] Pneumonol Alergol Pol. 2008;76(5):353-9 [19003766.001]
  • [Cites] Respiration. 1992;59 Suppl 3:19-23 [1439235.001]
  • [Cites] Clin Ther. 2000 Jun;22(6):748-59 [10929921.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 1988;50(6):397-404 [3068610.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):831-6 [11158556.001]
  • [Cites] Eur J Pediatr. 2007 Apr;166(4):365-76 [17115184.001]
  • [Cites] Nan Fang Yi Ke Da Xue Xue Bao. 2007 Oct;27(10):1612-3 [17959549.001]
  • [Cites] J Investig Allergol Clin Immunol. 1999 May-Jun;9(3):178-82 [10412680.001]
  • [Cites] Schweiz Rundsch Med Prax. 1982 Sep 7;71(36):1385-9 [6752937.001]
  • [Cites] Pain. 2006 Apr;121(3):207-18 [16495012.001]
  • [Cites] Schweiz Med Wochenschr. 1984 Jun 23;114(25):932-4 [6379870.001]
  • [Cites] BMJ. 2003 Jul 5;327(7405):36-40 [12842956.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 1990 Jun;19(2):151-61 [2373599.001]
  • [Cites] Clin Diagn Lab Immunol. 2001 Sep;8(5):1012-4 [11527819.001]
  • [Cites] Control Clin Trials. 1996 Feb;17(1):1-12 [8721797.001]
  • [Cites] Cesk Pediatr. 1989 Aug;44(8):454-8 [2791096.001]
  • [Cites] Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004974 [17054227.001]
  • [Cites] Eur Respir J. 1999 Jul;14(1):4-11 [10489821.001]
  • [Cites] Allergol Immunopathol (Madr). 2003 Jan-Feb;31(1):7-13 [12573204.001]
  • [Cites] Respiration. 1990;57(2):90-9 [2122507.001]
  • [Cites] Respiration. 1991;58(3-4):150-4 [1745846.001]
  • [Cites] Immunol Lett. 2001 Feb 1;76(1):63-7 [11222915.001]
  • [Cites] BMJ. 2001 Feb 17;322(7283):390-5 [11179155.001]
  • [Cites] Wiad Lek. 1994 Jul;47(13-14):510-3 [7716937.001]
  • [Cites] BMJ. 2006 Oct 14;333(7572):782 [17028106.001]
  • [Cites] Respiration. 1994;61 Suppl 1:20-3 [7800967.001]
  • [Cites] N Engl J Med. 1997 Aug 21;337(8):536-42 [9262498.001]
  • (PMID = 20143206.001).
  • [ISSN] 1867-0687
  • [Journal-full-title] World journal of pediatrics : WJP
  • [ISO-abbreviation] World J Pediatr
  • [Language] eng
  • [Publication-type] Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Adjuvants, Immunologic; 0 / Broncho-Vaxom; 0 / Cell Extracts
  • [Number-of-references] 44
  •  go-up   go-down


22. Heng JL, Chen YC, Quah TC, Liu TC, Yeoh AE: Dedicated cytogenetics factor is critical for improving karyotyping results for childhood leukaemias - experience in the National University Hospital, Singapore 1989-2006. Ann Acad Med Singapore; 2010 Feb;39(2):102-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dedicated cytogenetics factor is critical for improving karyotyping results for childhood leukaemias - experience in the National University Hospital, Singapore 1989-2006.
  • INTRODUCTION: Childhood leukaemia accounts for more than 40% of new childhood cancer cases.
  • Unfortunately, karyotyping of childhood leukaemia is difficult, laborious and often unsuccessful.
  • Among them, 369 newly diagnosed and relapsed childhood acute leukaemia cases [281 acute lymphoblastic leukaemia (ALL) and 88 acute myeloid leukaemia (AML)] have been diagnosed at NUH.
  • [MeSH-major] Cytogenetic Analysis / methods. Leukemia, Myeloid, Acute / diagnosis. Leukemia, Myeloid, Acute / genetics

  • MedlinePlus Health Information. consumer health - Acute Myeloid Leukemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20237730.001).
  • [ISSN] 0304-4602
  • [Journal-full-title] Annals of the Academy of Medicine, Singapore
  • [ISO-abbreviation] Ann. Acad. Med. Singap.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Singapore
  •  go-up   go-down


23. von Neuhoff C, Reinhardt D, Sander A, Zimmermann M, Bradtke J, Betts DR, Zemanova Z, Stary J, Bourquin JP, Haas OA, Dworzak MN, Creutzig U: Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98. J Clin Oncol; 2010 Jun 1;28(16):2682-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
  • PURPOSE: Because cytogenetic data are essential for risk stratification of childhood acute myeloid leukemia (AML), the impact of chromosomal aberrations is crucial.
  • CONCLUSION: Because the prognostic value of rare recurrent chromosomal aberrations still has to be elucidated, these data will contribute to future risk stratification for the treatment of pediatric AML.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Chromosome Aberrations. Chromosomes, Human, Pair 21. Chromosomes, Human, Pair 8. Leukemia, Myeloid, Acute / genetics. Leukemia, Myeloid, Acute / therapy

  • Genetic Alliance. consumer health - Acute Myelocytic Leukemia.
  • Genetic Alliance. consumer health - Leukemia, Myeloid.
  • MedlinePlus Health Information. consumer health - Acute Myeloid Leukemia.
  • Hazardous Substances Data Bank. CYTARABINE .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20439630.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 04079A1RDZ / Cytarabine; 6PLQ3CP4P3 / Etoposide; ZRP63D75JW / Idarubicin; ICE protocol 4
  •  go-up   go-down


24. Hah JO: Anaplastic oligodendroglioma after childhood acute lymphoblastic leukemia: chemotherapy and autologous peripheral blood stem cell transplantation. J Pediatr Hematol Oncol; 2008 Oct;30(10):764-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anaplastic oligodendroglioma after childhood acute lymphoblastic leukemia: chemotherapy and autologous peripheral blood stem cell transplantation.
  • Secondary brain tumors after cranial irradiation occur in survivors of childhood acute lymphoblastic leukemia (ALL).
  • High-dose chemotherapy with stem cell rescue seems to be potentially effective for multiple recurrent anaplastic oligodendroglioma occurring after childhood ALL.
  • [MeSH-major] Neoplasms, Second Primary / therapy. Oligodendroglioma / therapy. Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications


25. Su WJ, Chen HL, Lai HS, Ni YH, Chang MH: Pancreaticobiliary anomalies is the leading cause of childhood recurrent pancreatitis. J Formos Med Assoc; 2007 Feb;106(2):119-25
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreaticobiliary anomalies is the leading cause of childhood recurrent pancreatitis.
  • BACKGROUND/PURPOSE: To explore the etiology, age and gender distribution, complications, and prognosis of recurrent pediatric pancreatitis.
  • Only 25 diagnosed with recurrent pancreatitis, based on two or more episodes of pancreatitis, elevated serum amylase and/or lipase levels > or = 3 times the upper limit of normal, radiographic evidence, and clinical symptoms, were enrolled.
  • The recurrence rate of pediatric pancreatitis was 27.2%.
  • Recurrent pancreatitis was associated with pancreaticobiliary structural anomalies (n = 7), biliary stones or sludge (n = 4), hyperlipidemia (n = 3), pseudopapillary tumor of the pancreas (n = 2), trauma (n = 2), hypoxic encephalopathy with recurrent bacteremia and sepsis (n = 1), and idiopathic (n = 6).
  • No patient died of recurrent pancreatitis.
  • Long-term morbidity after recurrent pancreatitis presented as gout, diabetes mellitus, non-alcoholic steatohepatitis, and chronic pancreatitis.
  • CONCLUSION: For children who suffer from recurrent pancreatitis, pancreaticobiliary structural anomalies should be considered first.

  • Genetic Alliance. consumer health - Pancreatitis.
  • MedlinePlus Health Information. consumer health - Pancreatitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17339155.001).
  • [ISSN] 0929-6646
  • [Journal-full-title] Journal of the Formosan Medical Association = Taiwan yi zhi
  • [ISO-abbreviation] J. Formos. Med. Assoc.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] Singapore
  •  go-up   go-down


26. Teitell MA, Pandolfi PP: Molecular genetics of acute lymphoblastic leukemia. Annu Rev Pathol; 2009;4:175-98
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular genetics of acute lymphoblastic leukemia.
  • Acute lymphoblastic leukemia (ALL) is mainly a disease of childhood that arises from recurrent genetic insults that block precursor B and T cell differentiation and drive aberrant cell proliferation and survival.
  • Recurrent defects including chromosomal translocations, aneuploidies, and gene-specific alterations generate molecular subgroups of B- and T-ALL with differing clinical courses and distinct responses to therapy.
  • Recent discoveries arising from genome-wide surveys and adoptive transfer of leukemia-initiating cells have uncovered multiple gene copy number aberrations and have yielded new insight into at least one type of ALL-originating cell.
  • Our understanding of the pathogenesis of ALL has benefited from genetically modified mouse models that recapitulate cellular transformation at specific developmental stages of lymphoid lineage cells.
  • Here, we review the spectrum of genetic aberrations that promote acute B and T cell leukemias and the mechanisms of cell transformation and malignant progression that are reinforced by mouse models of human ALL.
  • [MeSH-major] Cell Transformation, Neoplastic / genetics. Gene Expression Regulation, Leukemic. Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics

  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18783329.001).
  • [ISSN] 1553-4014
  • [Journal-full-title] Annual review of pathology
  • [ISO-abbreviation] Annu Rev Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 153
  •  go-up   go-down


27. Leach AJ, Morris PS: Antibiotics for the prevention of acute and chronic suppurative otitis media in children. Cochrane Database Syst Rev; 2006;(4):CD004401
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Antibiotics for the prevention of acute and chronic suppurative otitis media in children.
  • BACKGROUND: Acute otitis media (AOM) is a common childhood illness.
  • DATA COLLECTION AND ANALYSIS: Two authors independently extracted the data for: any AOM; episodes of AOM; any recurrent AOM; episodes of illness; any side effects; any antibiotic resistance, as well as outcomes at end of intervention (any AOM); and following cessation of intervention (any AOM).
  • [MeSH-minor] Acute Disease. Adolescent. Child. Child, Preschool. Chronic Disease. Humans. Infant. Infant, Newborn. Otitis Media / drug therapy. Randomized Controlled Trials as Topic. Secondary Prevention. Tympanic Membrane Perforation / prevention & control

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17054203.001).
  • [ISSN] 1469-493X
  • [Journal-full-title] The Cochrane database of systematic reviews
  • [ISO-abbreviation] Cochrane Database Syst Rev
  • [Language] eng
  • [Publication-type] Journal Article; Meta-Analysis; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents
  • [Number-of-references] 38
  •  go-up   go-down


28. Lech-Maranda E, Korycka A, Robak T: Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity. Mini Rev Med Chem; 2009 Jun;9(7):805-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Phase I/II clinical studies revealed its efficacy in hematological malignancies, and in 2004 clofarabine was approved by the United States Food and Drug Administration for the treatment of pediatric relapsed or refractory acute lymphoblastic leukemia after at least two prior chemotherapy regimens.

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • SciCrunch. DrugBank: Data: Chemical .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19519505.001).
  • [ISSN] 1389-5575
  • [Journal-full-title] Mini reviews in medicinal chemistry
  • [ISO-abbreviation] Mini Rev Med Chem
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Adenine Nucleotides; 0 / Antineoplastic Agents; 0 / Arabinonucleosides; 0 / Nucleosides; 762RDY0Y2H / clofarabine
  • [Number-of-references] 47
  •  go-up   go-down


29. Seymour NE, Andersen DK: Laparoscopic treatment of intestinal malrotation in adults. JSLS; 2005 Jul-Sep;9(3):298-301
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Congenital midgut malrotation is rarely encountered outside the pediatric population.
  • METHODS: Records were reviewed of 7 patients, ages 17 to 45, all with a history of abdominal discomfort dating from childhood or early adolescence.
  • Symptoms consisted of recurrent bouts of abdominal pain that were most often postprandial, with bloating and, less frequently, constipation.
  • CONCLUSIONS: Although rarely encountered, intestinal malrotation after childhood can produce significant clinical symptoms that respond to surgical treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Endosc. 1999 Nov;13(11):1160-2 [10556462.001]
  • [Cites] Trop Gastroenterol. 2001 Apr-Jun;22(2):93-4 [11552494.001]
  • [Cites] Br Med J. 1968 Mar 30;1(5595):803-7 [5641487.001]
  • [Cites] AJR Am J Roentgenol. 1976 Feb;126(2):358-67 [175705.001]
  • [Cites] J Clin Gastroenterol. 1987 Apr;9(2):212-6 [3571896.001]
  • [Cites] AMA Arch Surg. 1958 Oct;77(4):483-91 [13582407.001]
  • [Cites] Dig Dis Sci. 1993 Mar;38(3):438-44 [8444073.001]
  • [Cites] Dis Colon Rectum. 1994 Feb;37(2):192-8 [8306846.001]
  • [Cites] Surg Endosc. 1996 Sep;10(9):936-7 [8703156.001]
  • [Cites] Surg Endosc. 1998 Nov;12(11):1314-6 [9788854.001]
  • [Cites] Ann R Coll Surg Engl. 1990 Jul;72(4):239-42 [2382946.001]
  • (PMID = 16121875.001).
  • [ISSN] 1086-8089
  • [Journal-full-title] JSLS : Journal of the Society of Laparoendoscopic Surgeons
  • [ISO-abbreviation] JSLS
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3015603
  •  go-up   go-down


30. Hospach T, von den Driesch P, Dannecker GE: Acute febrile neutrophilic dermatosis (Sweet's syndrome) in childhood and adolescence: two new patients and review of the literature on associated diseases. Eur J Pediatr; 2009 Jan;168(1):1-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acute febrile neutrophilic dermatosis (Sweet's syndrome) in childhood and adolescence: two new patients and review of the literature on associated diseases.
  • OBJECTIVES: The objectives of this study were to analyse the literature on Sweet's syndrome in childhood focussing on associated diseases and to suggest possible screening procedures for this group of patients.
  • RESULTS: The literature search revealed 64 patients (including our two patients) who were diagnosed with Sweet's syndrome in childhood and adolescence; 27 (42%) patients were categorized as "classic/idiopathic Sweet's syndrome".
  • Out of these, 21 (33%) patients were categorized as "parainflammatory Sweet's syndrome" including chronic recurrent multifocal osteomyelitis, vasculitis with aortitis, recurrent infections due to immunodeficiencies, arthritis, and systemic lupus erythematosus.
  • Sixteen (25%) patients were categorized as "paraneoplastic Sweet's syndrome" comprising both malignant and premalignant diseases like leukemia, aplastic anaemia, and Fanconi anaemia.
  • Two new children with Sweet's syndrome and associated diseases are presented here, one of them suffering from recurrent infections and trisomy 21, while the other was diagnosed with CNS vasculitis 5(1/2) years after the primary diagnosis.
  • As most cases of pediatric Sweet's syndrome are associated with other diseases we suggest careful screening and monitoring of these patients especially concerning malignant/premalignant diseases, immunodeficiencies, cardiovascular involvement, autoimmune diseases, and drug associations.
  • [MeSH-minor] Acute Disease. Adolescent. Child. Child, Preschool. Diagnosis, Differential. Female. Humans. Immunoglobulins / blood. Infant. Male. Neutropenia / diagnosis. Severity of Illness Index

  • Genetic Alliance. consumer health - Neutrophilic dermatosis, acute febrile.
  • MedlinePlus Health Information. consumer health - Fever.
  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for acute febrile neutrophilic dermatosis .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dermatol Clin. 2002 Jul;20(3):409-19 [12170875.001]
  • [Cites] Ann Dermatol Venereol. 2005 Jan;132(1):32-4 [15746604.001]
  • [Cites] Pediatr Pathol. 1983 Apr-Jun;1(2):199-210 [6387674.001]
  • [Cites] Pediatr Infect Dis J. 1987 Jan;6(1):77-9 [3469614.001]
  • [Cites] Arch Dermatol. 1983 Dec;119(12):998-1002 [6651317.001]
  • [Cites] Pediatr Dermatol. 1999 May-Jun;16(3):214-6 [10383779.001]
  • [Cites] Pediatrie. 1983 Jun;38(4):253-9 [6622145.001]
  • [Cites] Pediatr Dermatol. 1985 Nov;3(1):40-4 [3906610.001]
  • [Cites] Med J Zambia. 1983 Jul;17(3):92-3 [6679158.001]
  • [Cites] South Med J. 1994 Feb;87(2):193-6 [8115882.001]
  • [Cites] N Engl J Med. 2006 Aug 24;355(8):788-98 [16928994.001]
  • [Cites] Clin Pediatr (Phila). 2002 Apr;41(3):175-7 [11999681.001]
  • [Cites] J Am Acad Dermatol. 1999 May;40(5 Pt 2):838-41 [10321630.001]
  • [Cites] Lupus. 2005;14(12):974-5 [16425580.001]
  • [Cites] Med Pediatr Oncol. 1998 Sep;31(3):178-81 [9722904.001]
  • [Cites] Br J Haematol. 1994 Feb;86(2):415-7 [7515269.001]
  • [Cites] Ann Acad Med Singapore. 1996 Mar;25(2):222-7 [8799010.001]
  • [Cites] Arch Pediatr. 2000 May;7(5):501-4 [10855388.001]
  • [Cites] Eur J Pediatr. 1986 Sep;145(4):303-5 [3769998.001]
  • [Cites] J Pediatr Hematol Oncol. 2001 Jan;23(1):59-62 [11196274.001]
  • [Cites] J Pediatr. 1989 Nov;115(5 Pt 1):726-9 [2809903.001]
  • [Cites] Indian J Pediatr. 1993 Jul-Aug;60(4):573-81 [8262594.001]
  • [Cites] Pediatrics. 1999 Nov;104(5 Pt 1):1142-4 [10545563.001]
  • [Cites] Pediatr Dermatol. 1992 Sep;9(3):288-92 [1488383.001]
  • [Cites] S Afr Med J. 1978 Feb 18;53(7):253-6 [653521.001]
  • [Cites] J Pediatr. 1983 Feb;102(2):243-8 [6822929.001]
  • [Cites] J Am Acad Dermatol. 1994 Oct;31(4):535-56; quiz 557-60 [8089280.001]
  • [Cites] Br J Dermatol. 1991 Feb;124(2):203-6 [2004008.001]
  • [Cites] Arch Dermatol. 1996 Dec;132(12):1507, 1510 [8961884.001]
  • [Cites] Pediatrics. 1996 Mar;97(3):401-3 [8604280.001]
  • [Cites] Pediatr Crit Care Med. 2002 Apr;3(2):190-193 [12780994.001]
  • [Cites] Indian Pediatr. 1998 Oct;35(10):1017-20 [10216728.001]
  • [Cites] Ann Rheum Dis. 2005 Jan;64(1):168-9 [15608327.001]
  • [Cites] Pediatr Hematol Oncol. 1993 Oct-Dec;10(4):343-6 [8292519.001]
  • [Cites] J Rheumatol. 1985 Oct;12(5):1000-3 [4087247.001]
  • [Cites] Nippon Ganka Gakkai Zasshi. 2004 Mar;108(3):162-5 [15103953.001]
  • [Cites] Med Pediatr Oncol. 2003 Feb;40(2):135-6 [12461805.001]
  • [Cites] J Rheumatol. 1999 Feb;26(2):440-2 [9972982.001]
  • [Cites] Br J Dermatol. 1964 Aug-Sep;76:349-56 [14201182.001]
  • [Cites] Cutis. 1996 Feb;57(2):107-10 [8646854.001]
  • [Cites] Arch Dermatol. 1998 May;134(5):625-6, 628-9 [9606334.001]
  • [Cites] Pediatr Dermatol. 2005 Nov-Dec;22(6):530-5 [16354255.001]
  • [Cites] Pediatr Infect Dis J. 1999 Jun;18(6):568-70 [10391198.001]
  • [Cites] Arch Dermatol. 2002 Mar;138(3):345-9 [11902985.001]
  • [Cites] Pediatr Dermatol. 1994 Sep;11(3):237-40 [7971558.001]
  • [Cites] J Am Acad Dermatol. 2003 Jul;49(1):132-8 [12833027.001]
  • [Cites] Z Hautkr. 1986 Oct 1;61(19):1351-60 [2947392.001]
  • [Cites] Acta Haematol. 1988;80(4):224 [3146203.001]
  • [Cites] Ann Hematol. 2002 Feb;81(2):111-4 [11907794.001]
  • [Cites] Am J Dis Child. 1986 Aug;140(8):817-8 [3728413.001]
  • [Cites] Pediatr Dermatol. 1987 Dec;4(4):305-12 [3481857.001]
  • [Cites] Postgrad Med J. 1997 Feb;73(856):65-8 [9122099.001]
  • [Cites] J Pediatr Hematol Oncol. 2002 Jan;24(1):64-8 [11902745.001]
  • [Cites] J Pediatr Hematol Oncol. 2004 Mar;26(3):197-9 [15125614.001]
  • [Cites] J Pediatr. 1989 Nov;115(5 Pt 1):730-4 [2809904.001]
  • [Cites] Ann Allergy. 1994 Feb;72(2):125-8 [8109801.001]
  • [Cites] Pediatr Dermatol. 2005 Nov-Dec;22(6):525-9 [16354254.001]
  • [Cites] Pediatr Cardiol. 1999 Jul-Aug;20(4):295-7 [10368458.001]
  • [Cites] Cancer. 1976 Feb;37(2):922-7 [766949.001]
  • [Cites] J Pediatr Hematol Oncol. 1996 Aug;18(3):282-4 [8689342.001]
  • [Cites] Br J Dermatol. 1980 Oct;103(4):449-51 [7437311.001]
  • [Cites] Pediatr Dermatol. 1993 Sep;10(3):298-9 [8415316.001]
  • [Cites] J Pediatr. 1981 Jul;99(1):73-8 [7252668.001]
  • (PMID = 18830624.001).
  • [ISSN] 1432-1076
  • [Journal-full-title] European journal of pediatrics
  • [ISO-abbreviation] Eur. J. Pediatr.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Immunoglobulins
  • [Number-of-references] 64
  •  go-up   go-down


31. Yaprak I, Atabay B, Durak İ, Türker M, Öniz H, Arun Özer E: Variant clinical courses in children with immune thrombocytopenic purpura: Sixteen year experience of a single medical center. Turk J Haematol; 2010 Sep 5;27(3):147-55
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients with acute vs chronic ITP, acute vs recurrent ITP and chronic vs recurrent ITP were compared in terms of age at diagnosis, gender, initial platelet count, response rate to initial therapy, long-term outcome, and total duration of follow-up.
  • RESULTS: The clinical courses of the patients were determined as acute, chronic and recurrent in 63.8%, 29.1%, and 7.1%, respectively.
  • CONCLUSION: It is concluded that ITP in childhood is a common disease with low morbidity and mortality.
  • In addition to the acute and chronic form, a rare recurrent form, which accounts for about 4-7% of all ITP patients, should be considered.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27263598.001).
  • [ISSN] 1300-7777
  • [Journal-full-title] Turkish journal of haematology : official journal of Turkish Society of Haematology
  • [ISO-abbreviation] Turk J Haematol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


32. Yang A, Wickremesekera A, Parker A, Davis C: Surgical management of craniofacial and skull base rhabdomyosarcomas. J Craniofac Surg; 2009 Sep;20(5):1388-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • One had a recurrent tumor, and 3 had functional reconstruction after an earlier treatment.
  • Late consequences of early childhood craniofacial cancer treatment may be ameliorated by tailored reconstructions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19816263.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


33. McTague A, Appleton R: Episodic dyscontrol syndrome. Arch Dis Child; 2010 Oct;95(10):841-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The episodes comprise of recurrent attacks of uncontrollable rage, usually after minimal provocation, and may last up to an hour.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20515972.001).
  • [ISSN] 1468-2044
  • [Journal-full-title] Archives of disease in childhood
  • [ISO-abbreviation] Arch. Dis. Child.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


34. Matsuzaki A, Nagatoshi Y, Inada H, Nakayama H, Yanai F, Ayukawa H, Kawakami K, Moritake H, Suminoe A, Okamura J: Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group. Pediatr Blood Cancer; 2005 Aug;45(2):111-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
  • BACKGROUND: The treatment results of childhood acute lymphoblastic leukemia (ALL) with a first relapse were retrospectively analyzed to determine prognostic factors.
  • [MeSH-major] Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy. Stem Cell Transplantation


35. Simon TD, Soep JB, Hollister JR: Pernio in pediatrics. Pediatrics; 2005 Sep;116(3):e472-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Five cases were seen among adolescent female patients who presented to our rheumatology service in a pediatric tertiary care center in the winter of 2003 to 2004.
  • Acute pernio may develop 12 to 24 hours after exposure to the cold.
  • In an acute exacerbation, the major differential diagnosis alternative would be Raynaud's phenomenon, which consists of sharply demarcated cutaneous pallor and cyanosis, followed by erythema, of far shorter duration (hours rather than days).
  • The lesions of acute pernio are usually self-limited but may lead to recurrent disease.
  • General pediatricians, particularly those who practice in colder climates, should be aware of the presentation and treatment of pernio in childhood.
  • [MeSH-minor] Acute Disease. Adolescent. Adult. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16140694.001).
  • [ISSN] 1098-4275
  • [Journal-full-title] Pediatrics
  • [ISO-abbreviation] Pediatrics
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


36. Wagner-Bohn A, Paulussen M, Vieira Pinheiro JP, Gerss J, Stoffregen C, Boos J: Phase II study of gemcitabine in children with solid tumors of mesenchymal and embryonic origin. Anticancer Drugs; 2006 Aug;17(7):859-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The therapeutic benefit and side-effect profile of gemcitabine in adults with relapsed solid tumors is well known.
  • So far, few data are available about its significance in pediatric relapsed solid tumors.
  • To determine the efficacy and tolerability of gemcitabine in children, the drug was administered by intravenous short-term infusion over 30 min at a dose of 1200 mg/m2 weekly for 3 weeks as one cycle in children with relapsed solid tumor of embryonic or mesenchymal origin.

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16926636.001).
  • [ISSN] 0959-4973
  • [Journal-full-title] Anti-cancer drugs
  • [ISO-abbreviation] Anticancer Drugs
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine
  •  go-up   go-down


37. Balemans WA, Rovers MM, Schilder AG, Sanders EA, Kimpen JL, Zielhuis GA, Ent CK: Recurrent childhood upper respiratory tract infections do not reduce the risk of adult atopic disease. Clin Exp Allergy; 2006 Feb;36(2):198-203
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent childhood upper respiratory tract infections do not reduce the risk of adult atopic disease.
  • Longitudinal studies investigating these associations beyond childhood are, however, scarce.
  • OBJECTIVE: To investigate the association between childhood recurrent upper respiratory tract infections (URTI) and asthma, allergic rhinitis (AR) and eczema in adulthood.
  • Children who experienced recurrent URTI before the age of 2 years, between the ages of 2-4 years and between ages of 4 and 8 years were not less likely to have asthma at 21 years of age than children who did not experience recurrent URTI, relative risk (RR) 0.97 (95% confidence interval (CI) 0.65-1.46), RR 1.45 (CI 0.95-2.21) and RR 1.51 (CI 0.97-2.36), respectively.
  • Neither were recurrent URTI associated with a decreased risk of AR, nor eczema at the age of 21 years.
  • CONCLUSIONS: Recurrent URTI in childhood did not reduce the risk of atopic disease in young adulthood.

  • MedlinePlus Health Information. consumer health - Allergy.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16433857.001).
  • [ISSN] 0954-7894
  • [Journal-full-title] Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • [ISO-abbreviation] Clin. Exp. Allergy
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


38. Jetsrisuparb A, Wiangnon S, Komvilaisak P, Kularbkaew C, Yutanawiboonchai W, Mairieng E: Rituximab combined with CHOP for successful treatment of aggressive recurrent, pediatric B-cell large cell non-Hodgkin's lymphoma. J Pediatr Hematol Oncol; 2005 Apr;27(4):223-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rituximab combined with CHOP for successful treatment of aggressive recurrent, pediatric B-cell large cell non-Hodgkin's lymphoma.
  • This report is the first to describe the successful treatment of a 14-year-old boy with aggressive recurrent, CD20-positive, B-cell large cell non-Hodgkin's lymphoma.
  • Rituximab and CHOP in addition to chemotherapy may be an alternative treatment for aggressive recurrent, pediatric CD20-positive B-cell large cell non-Hodgkin's lymphoma if highly intensive chemotherapy and stem cell transplantation are not available.

  • Genetic Alliance. consumer health - Lymphoma, large-cell.
  • Hazardous Substances Data Bank. RITUXIMAB .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15838396.001).
  • [ISSN] 1077-4114
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 4F4X42SYQ6 / Rituximab; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
  •  go-up   go-down


39. High LM, Szymanska B, Wilczynska-Kalak U, Barber N, O'Brien R, Khaw SL, Vikstrom IB, Roberts AW, Lock RB: The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs. Mol Pharmacol; 2010 Mar;77(3):483-94
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs.
  • We show that ABT-737 was effective as a single agent against a panel of pediatric acute lymphoblastic leukemia (ALL) xenografts, previously established, from patient biopsies, in immunodeficient mice.
  • Although in vitro resistance of leukemia cell lines correlated with expression of the prosurvival protein Mcl-1, there was no relationship between Mcl-1 expression and in vivo xenograft response to ABT-737.
  • Rational targeting of specific components of the apoptotic pathway may be a useful approach to improve the treatment of refractory or relapsed pediatric ALL.
  • Overall, this study supports the inclusion of the clinical derivative of ABT-737, ABT-263 (for structure, see Cancer Res 68:3421-3428, 2008), into clinical trials against relapsed/refractory pediatric ALL.
  • [MeSH-major] Antineoplastic Agents / administration & dosage. Apoptosis / drug effects. Biphenyl Compounds / administration & dosage. Drug Delivery Systems / methods. Molecular Mimicry. Nitrophenols / administration & dosage. Pharmaceutical Preparations / metabolism. Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy. Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors. Sulfonamides / administration & dosage

  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia.
  • MedlinePlus Health Information. consumer health - Medicines.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20038611.001).
  • [ISSN] 1521-0111
  • [Journal-full-title] Molecular pharmacology
  • [ISO-abbreviation] Mol. Pharmacol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / ABT-737; 0 / Antineoplastic Agents; 0 / Biphenyl Compounds; 0 / Nitrophenols; 0 / Pharmaceutical Preparations; 0 / Piperazines; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Sulfonamides
  •  go-up   go-down


40. Pasic S, Vujic D, Djuricic S, Jevtic D, Grujic B: Burkitt lymphoma-induced ileocolic intussusception in Wiskott-Aldrich syndrome. J Pediatr Hematol Oncol; 2006 Jan;28(1):48-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 12-year-old patient with Wiskott-Aldrich syndrome (WAS) was referred because of recurrent abdominal pain and bloody stools.
  • Burkitt lymphoma represents 40% to 50% of all NHL cases in childhood, but in WAS it has rarely been reported.

  • Genetic Alliance. consumer health - Wiskott Aldrich syndrome.
  • MedlinePlus Health Information. consumer health - Small Intestine Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16394894.001).
  • [ISSN] 1077-4114
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


41. Morikawa N, Kuroda T, Honna T, Kitano Y, Fuchimoto Y, Terawaki K, Kawasaki K, Koinuma G, Matsuoka K, Saeki M: Congenital bronchial atresia in infants and children. J Pediatr Surg; 2005 Dec;40(12):1822-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study was to clarify the clinical characteristics of CBA in childhood and to describe the spectrum of this condition.
  • The most frequent symptom was productive cough and fever owing to recurrent pneumonia found in 26 children.
  • Bronchial atresia is a distinct pathological entity that accounts for recurrent pneumonia or respiratory distress in childhood, requiring surgical treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16338298.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


42. Ballhausen D, Guerry F, Hahn D, Schaller A, Nuoffer JM, Bonafé L, Jeannet PY, Jacquemont S: Mitochondrial tRNA(Leu(UUR)) mutation m.3302A &gt; G presenting as childhood-onset severe myopathy: threshold determination through segregation study. J Inherit Metab Dis; 2010 Dec;33 Suppl 3:S219-26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mitochondrial tRNA(Leu(UUR)) mutation m.3302A > G presenting as childhood-onset severe myopathy: threshold determination through segregation study.
  • At 8 years, the patient is wheel-chair bound, requires nocturnal assisted ventilation, and suffers from recurrent respiratory infections.

  • Genetic Alliance. consumer health - Mitochondrial myopathy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nucleic Acids Res. 2006;34(22):6404-15 [17130166.001]
  • [Cites] Biol Chem. 2001 Aug;382(8):1147-56 [11592395.001]
  • [Cites] Clin Chim Acta. 1984 Jun 27;140(1):39-46 [6430598.001]
  • [Cites] BMJ. 2009 Jan 30;338:b94 [19181733.001]
  • [Cites] Arch Neurol. 2005 Dec;62(12):1920-3 [16344351.001]
  • [Cites] Neuromuscul Disord. 2000 Aug;10(6):460-2 [10899455.001]
  • [Cites] Methods Cell Biol. 2001;65:97-117 [11381612.001]
  • [Cites] Clin Chim Acta. 1994 Jul;228(1):35-51 [7955428.001]
  • [Cites] J Mol Biol. 2004 Mar 26;337(3):535-44 [15019775.001]
  • [Cites] J Biol Chem. 1993 Sep 15;268(26):19559-64 [8366098.001]
  • [Cites] Curr Opin Neurol. 2007 Oct;20(5):564-71 [17885446.001]
  • [Cites] Nat Genet. 1999 Oct;23(2):147 [10508508.001]
  • [Cites] Neuromuscul Disord. 2004 Oct;14(10):683-8 [15351426.001]
  • [Cites] J Clin Invest. 1990 Jan;85(1):177-84 [2153151.001]
  • [Cites] Biochim Biophys Acta. 2003 Sep 23;1642(1-2):115-23 [12972300.001]
  • [Cites] Biochem J. 1969 Sep;114(3):597-610 [5820645.001]
  • (PMID = 20458543.001).
  • [ISSN] 1573-2665
  • [Journal-full-title] Journal of inherited metabolic disease
  • [ISO-abbreviation] J. Inherit. Metab. Dis.
  • [Language] eng
  • [Databank-accession-numbers] OMIM/ 590050
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / RNA, mitochondrial; 63231-63-0 / RNA; 9014-25-9 / RNA, Transfer
  •  go-up   go-down


43. Prakash S, Shah ND, Dholakia SY: Recurrent limb pain and migraine: case reports and a clinical review. Cephalalgia; 2009 Aug;29(8):898-905
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent limb pain and migraine: case reports and a clinical review.
  • Recurrent limb pain (RLP) is a well-known entity in childhood.
  • It is considered a precursor of migraine.
  • The temporal relationship of RLP with headache in childhood is lacking in the literature.
  • Three patients had a history of RLP in childhood and developed migraine headache after many years.

  • Genetic Alliance. consumer health - Migraine.
  • MedlinePlus Health Information. consumer health - Migraine.
  • MedlinePlus Health Information. consumer health - Pain.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19220300.001).
  • [ISSN] 1468-2982
  • [Journal-full-title] Cephalalgia : an international journal of headache
  • [ISO-abbreviation] Cephalalgia
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


44. Piitulainen E, Carlson J, Ohlsson K, Sveger T: Alpha1-antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease/protease inhibitor studies. Chest; 2005 Oct;128(4):2076-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The effect of early childhood environment and symptoms was also studied.
  • Four current smokers (67%) and 22% of ex-smokers/never-smokers reported recurrent wheezing (p = 0.03).
  • Recurrent wheezers at age 2 years with AAT deficiency had decreased FEV1/FVC ratio (p = 0.025) at age 26 years.
  • [MeSH-minor] Acute-Phase Proteins. Adult. Blood Proteins / metabolism. Humans. Lipocalins. Liver Function Tests. Neutrophils / physiology. Proto-Oncogene Proteins / blood


45. McDonald MI, Towers RJ, Andrews RM, Benger N, Currie BJ, Carapetis JR: Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis; 2006 Sep 15;43(6):683-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic.
  • BACKGROUND: Acute rheumatic fever is a major cause of heart disease in Aboriginal Australians.
  • A link between pyoderma and acute rheumatic fever has been proposed but is yet to be proven.
  • RESULTS: From data collected during 531 household visits, the childhood incidence of sore throat was calculated to be 8 cases per 100 person-years, with no cases of symptomatic group A beta-hemolytic streptococci pharyngitis.
  • CONCLUSIONS: These data are consistent with the hypothesis that recurrent skin infections immunize against throat colonization and infection.
  • High rates of acute rheumatic fever were not driven by symptomatic group A beta-hemolytic streptococci throat infection.


46. Picas-Jufresa A, Lladó-Puigdemont A, Buñuel-Alvarez JC, Vila-Pablos C: [Recurrent community acquired pneumonia in young children: risk factor for the development of childhood asthma?]. Aten Primaria; 2006 Feb 28;37(3):127-31; discussion 131-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Recurrent community acquired pneumonia in young children: risk factor for the development of childhood asthma?].
  • OBJECTIVE: To determine if recurrent community acquired pneumonia (RP) is a risk factor for developing childhood asthma (CA), compared with those children who only suffer one episode of pneumonia or non-recurrent pneumonia (NRP).
  • PRINCIPAL MEASUREMENTS: The relative risk (RR) and confidence interval (95% CI) of childhood asthma in the presence of recurrent pneumonia as compared to non-recurrent pneumonia, and the RR of recurrent pneumonia in the presence of childhood asthma.


47. Bernard TJ, deVeber GA, Benke TA: Athletic participation after acute ischemic childhood stroke: a survey of pediatric stroke experts. J Child Neurol; 2007 Aug;22(8):1050-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Athletic participation after acute ischemic childhood stroke: a survey of pediatric stroke experts.
  • Minimal evidence exists about the risk of recurrent childhood acute ischemic stroke in patients subjected to a subsequent head or neck injury.
  • Recurrent or multiple dissections have been demonstrated in select cases.
  • Minor head trauma has also been associated with acute ischemic stroke.
  • The objective of this study was to survey pediatric stroke experts about participation of patients following acute ischemic stroke in high impact, medium impact, and low impact exercise.
  • International Pediatric Stroke Study members were surveyed about athletic participation after stroke.
  • Participants were asked about 2 scenarios: acute ischemic stroke with dissection, and acute ischemic stroke with a negative coagulation work-up and a negative angiogram.
  • Many experts would not allow high impact sports after a dissection, but disagree about recommendations after idiopathic acute ischemic stroke.
  • [MeSH-minor] Acute Disease. Adolescent. Age Factors. Brain / blood supply. Brain / pathology. Brain / physiopathology. Football / injuries. Humans. Male. Prognosis. Risk Assessment. Risk Factors. Secondary Prevention. Soccer / injuries. Vertebral Artery Dissection / complications. Vertebral Artery Dissection / physiopathology. Vertebral Artery Dissection / prevention & control


48. d'Andiran G, Schindler C, Leuenberger P: The absence of dyspnoea, cough and wheezing: a reason for undiagnosed airflow obstruction? Swiss Med Wkly; 2006 Jul 8;136(27-28):425-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PFTs were performed whenever an OLD history or another lung disease was present and, in the absence of any dyspnoea, cough and wheezing, when other symptoms and conditions occurred (sputum, chest tightness, fatigue, rhinitis, snoring; active/passive smoking, recurrent lower respiratory tract infections, asthma in childhood or in family, atopy).

  • MedlinePlus Health Information. consumer health - Breathing Problems.
  • MedlinePlus Health Information. consumer health - Choking.
  • MedlinePlus Health Information. consumer health - Cough.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16862462.001).
  • [ISSN] 1424-7860
  • [Journal-full-title] Swiss medical weekly
  • [ISO-abbreviation] Swiss Med Wkly
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


49. Guissard G, Damry N, Dan B, David P, Sékhara T, Ziereisen F, Christophe C: [Imaging in paediatric epilepsy]. Arch Pediatr; 2005 Mar;12(3):337-46
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Epilepsy is a chronic disease, often with an onset during childhood and characterized by spontaneous and recurrent seizures.
  • The recently developed diffusion-weighted sequence is particularly useful in the acute phase of certain events such as hypoxia-ischemia, trauma and metabolic disease.

  • Genetic Alliance. consumer health - Epilepsy.
  • MedlinePlus Health Information. consumer health - Epilepsy.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15734136.001).
  • [ISSN] 0929-693X
  • [Journal-full-title] Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie
  • [ISO-abbreviation] Arch Pediatr
  • [Language] fre
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


50. Hayes D Jr, Iocono JA, Bennett JS, Lachman DC, Ballard HO: Epistaxis due to Wegener's granulomatosis in a pediatric patient. Am J Otolaryngol; 2010 Sep-Oct;31(5):368-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epistaxis due to Wegener's granulomatosis in a pediatric patient.
  • Childhood vasculitides are very rare and are commonly diagnosed by characteristic lesions on imaging studies along with syndrome recognition by clinicians.
  • We present a case of recurrent epistaxis that persisted over 3 months due to Wegener's granulomatosis in an adolescent that was misdiagnosed as a benign hemorrhage from Kiesselbach's plexus.

  • Genetic Alliance. consumer health - Wegener's granulomatosis.
  • MedlinePlus Health Information. consumer health - Granulomatosis with Polyangiitis.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20015782.001).
  • [ISSN] 1532-818X
  • [Journal-full-title] American journal of otolaryngology
  • [ISO-abbreviation] Am J Otolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Antineutrophil Cytoplasmic; EC 3.4.21.76 / Myeloblastin
  •  go-up   go-down


51. Peny JM, Gleizes O, Covilard JP: Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective. Vaccine; 2005 Aug 31;23(37):4610-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The objective of this study was to anticipate the funding needs for childhood immunisation in developing countries over the 2004-2014 period.
  • Non-vaccine costs (capital costs and non-vaccine recurrent costs) were estimated based on the number of people immunised and number of doses dispensed, using available case studies as a reference.
  • Vaccines-related costs represent the largest share, with estimated costs of US$ 21 billion (among which 18 billion for new vaccines), the remaining needs being split between capital costs and other recurrent costs.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15979769.001).
  • [ISSN] 0264-410X
  • [Journal-full-title] Vaccine
  • [ISO-abbreviation] Vaccine
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


52. Cehajic-Kapetanovic J, Kwartz J: Augmentin duo™ in the treatment of childhood blepharokeratoconjunctivitis. J Pediatr Ophthalmol Strabismus; 2010 Nov-Dec;47(6):356-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Augmentin duo™ in the treatment of childhood blepharokeratoconjunctivitis.
  • PURPOSE: To report the use of Augmentin Duo 400/57 (GlaxoSmithKline, Middlesex, UK) in the treatment of childhood blepharokeratoconjunctivitis (BKC).
  • Diagnostic criteria for BKC were blepharitis including recurrent chalazia and meibomian gland dysfunction, eyelid margin telangiectasia and facial rosacea, recurrent episodes of chronic red eye, photophobia, watering, punctate superficial keratopathy, corneal neovascularization, and corneal ulcers.

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010, SLACK Incorporated.
  • (PMID = 20143765.001).
  • [ISSN] 1938-2405
  • [Journal-full-title] Journal of pediatric ophthalmology and strabismus
  • [ISO-abbreviation] J Pediatr Ophthalmol Strabismus
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 74469-00-4 / Amoxicillin-Potassium Clavulanate Combination
  •  go-up   go-down


53. Hasselmann MH, Reichenheim ME: Parental violence and the occurrence of severe and acute malnutrition in childhood. Paediatr Perinat Epidemiol; 2006 Jul;20(4):299-311
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Parental violence and the occurrence of severe and acute malnutrition in childhood.
  • Evidence from developed countries has linked family violence with severe acute malnutrition (SAM), yet no similar studies have been conducted in developing countries where the risk of SAM is higher.
  • Moreover, these findings indicate that the risk for SAM is not associated with all types of IPV, but that children exposed to severe and recurrent events are more likely to be admitted for SAM.
  • [MeSH-minor] Acute Disease. Aggression / psychology. Body Weight. Brazil / epidemiology. Case-Control Studies. Child, Preschool. Humans. Infant. Interpersonal Relations. Models, Psychological. Models, Statistical. Risk Factors. Socioeconomic Factors

  • MedlinePlus Health Information. consumer health - Domestic Violence.
  • MedlinePlus Health Information. consumer health - Infant and Newborn Nutrition.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16879502.001).
  • [ISSN] 0269-5022
  • [Journal-full-title] Paediatric and perinatal epidemiology
  • [ISO-abbreviation] Paediatr Perinat Epidemiol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


54. Noble SL, Sherer E, Hannemann RE, Ramkrishna D, Vik T, Rundell AE: Using adaptive model predictive control to customize maintenance therapy chemotherapeutic dosing for childhood acute lymphoblastic leukemia. J Theor Biol; 2010 Jun 7;264(3):990-1002
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Using adaptive model predictive control to customize maintenance therapy chemotherapeutic dosing for childhood acute lymphoblastic leukemia.
  • Acute lymphoblastic leukemia (ALL) is a common childhood cancer in which nearly one-quarter of patients experience a disease relapse.
  • However, it has been shown that individualizing therapy for childhood ALL patients by adjusting doses based on the blood concentration of active drug metabolite could significantly improve treatment outcome.
  • An adaptive model predictive control (MPC) strategy is presented in which maintenance therapy for childhood ALL is personalized using routine patient measurements of red blood cell mean corpuscular volume as a surrogate for the active drug metabolite concentration.
  • During the course of treatment, the patient-specific parameters are adaptively identified using recurrent complete blood count measurements, which sufficiently constrain the patient parameter uncertainty to support customized adjustments of the drug dose.
  • [MeSH-major] 6-Mercaptopurine / therapeutic use. Dose-Response Relationship, Drug. Models, Biological. Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy

  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia.
  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia, Childhood.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. MERCAPTOPURINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20138060.001).
  • [ISSN] 1095-8541
  • [Journal-full-title] Journal of theoretical biology
  • [ISO-abbreviation] J. Theor. Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, American Recovery and Reinvestment Act; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; E7WED276I5 / 6-Mercaptopurine
  •  go-up   go-down


55. Stanulla M, Schrappe M: Treatment of childhood acute lymphoblastic leukemia. Semin Hematol; 2009 Jan;46(1):52-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment of childhood acute lymphoblastic leukemia.
  • Childhood acute lymphoblastic leukemia (ALL) is the most common malignancy of childhood.
  • Studies in ALL have been a model for clinical and basic research beyond pediatric hemato-oncology.
  • As a result of sustained and well-organized research efforts since the early 1960s, childhood ALL now can be successfully treated in about 80% of patients by the application of intensive combination chemotherapy regimens, which in specific patient subgroups may need to be supplemented with radiation therapy and/or hematopoietic stem cell transplantation.
  • While the goal of effective therapy for the majority of children with ALL has been achieved, significant numbers of patients still die due to recurrent disease or the toxicity of treatment.
  • Thus, future research must extend our molecular understanding of leukemia and host factors in order to even more specifically identify the mechanisms underlying the differences in treatment response and outcome, and to finally address the therapeutic needs of the individual child.
  • [MeSH-major] Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy


56. Davidsson J, Paulsson K, Lindgren D, Lilljebjörn H, Chaplin T, Forestier E, Andersen MK, Nordgren A, Rosenquist R, Fioretos T, Young BD, Johansson B: Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations. Leukemia; 2010 May;24(5):924-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations.
  • Although childhood high hyperdiploid acute lymphoblastic leukemia is associated with a favorable outcome, 20% of patients still relapse.
  • No single aberration was linked to relapse, but four deletions, involving IKZF1, PAX5, CDKN2A/B or AK3, were recurrent.
  • [MeSH-major] Chromosome Deletion. Diploidy. Genes, ras / genetics. Mutation / genetics. Neoplasm Recurrence, Local / genetics. Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics. Receptor Protein-Tyrosine Kinases / genetics


57. Chan KL: Laparoscopic repair of recurrent childhood inguinal hernias after open herniotomy. Hernia; 2007 Feb;11(1):37-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic repair of recurrent childhood inguinal hernias after open herniotomy.
  • BACKGROUND: Open repair of recurrent paediatric inguinal hernias (IH) is difficult and there is definite risk of damaging the vas deferens and testicular vessels during dissection of the previous open herniotomy field.
  • METHOD: Records of patients with recurrent IH that had LR after open repair were reviewed and evaluated retrospectively.
  • RESULTS: From September 2002 to October 2005, four boys and one girl (mean age 58.8 months) were treated in our institution for recurrent IH after open repair.
  • CONCLUSION: Laparoscopic repair is the preferred operation for recurrent childhood IH after open repair.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Endosc. 2004 Jun;18(6):957-60 [15095082.001]
  • [Cites] J Pediatr Surg. 2002 Mar;37(3):395-7 [11877655.001]
  • [Cites] Surg Endosc. 2005 Jul;19(7):927-32 [15920685.001]
  • [Cites] J Am Coll Surg. 2003 Jun;196(6):987-9 [12788439.001]
  • [Cites] Br J Surg. 1985 Jun;72(6):485-7 [4016518.001]
  • [Cites] J Pediatr Surg. 2005 Jun;40(6):1009-14 [15991187.001]
  • [Cites] Acta Chir Belg. 1996 Feb;96(1):28-30 [8629384.001]
  • [Cites] J Pediatr Surg. 1991 Mar;26(3):283-7 [2030473.001]
  • [Cites] East Afr Med J. 1990 May;67(5):359-64 [2390959.001]
  • [Cites] J Pediatr Surg. 2002 May;37(5):745-51 [11987092.001]
  • (PMID = 17006622.001).
  • [ISSN] 1265-4906
  • [Journal-full-title] Hernia : the journal of hernias and abdominal wall surgery
  • [ISO-abbreviation] Hernia
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] France
  •  go-up   go-down


58. Diggle CP, Carr IM, Zitt E, Wusik K, Hopkin RJ, Prada CE, Calabrese O, Rittinger O, Punaro MG, Markham AF, Bonthron DT: Common and recurrent HPGD mutations in Caucasian individuals with primary hypertrophic osteoarthropathy. Rheumatology (Oxford); 2010 Jun;49(6):1056-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Common and recurrent HPGD mutations in Caucasian individuals with primary hypertrophic osteoarthropathy.
  • CONCLUSIONS: Biallelic HPGD mutations are found in the majority of patients with typical PHO, and sequencing of the HPGD gene is a highly specific first-line investigation for patients presenting in this way, particularly during childhood.
  • The c.175_176delCT frameshift mutation appears to be recurrent and to be the commonest HPGD mutation in Caucasian families.

  • SciCrunch. Clinical Genomic Database: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20299379.001).
  • [ISSN] 1462-0332
  • [Journal-full-title] Rheumatology (Oxford, England)
  • [ISO-abbreviation] Rheumatology (Oxford)
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / G84/6495; United Kingdom / Cancer Research UK / / ; United Kingdom / Medical Research Council / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] EC 1.1.1.- / Hydroxyprostaglandin Dehydrogenases; EC 1.1.1.141 / 15-hydroxyprostaglandin dehydrogenase
  •  go-up   go-down


59. Bateman CM, Colman SM, Chaplin T, Young BD, Eden TO, Bhakta M, Gratias EJ, van Wering ER, Cazzaniga G, Harrison CJ, Hain R, Ancliff P, Ford AM, Kearney L, Greaves M: Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia. Blood; 2010 Apr 29;115(17):3553-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia.
  • Chimeric fusion genes are highly prevalent in childhood acute lymphoblastic leukemia (ALL) and are mostly prenatal, early genetic events in the evolutionary trajectory of this cancer.
  • Recurrent CNAs are probably "driver" events contributing critically to clonal diversification and selection, but at diagnosis, their developmental timing is "buried" in the leukemia's covert natural history.
  • [MeSH-major] Gene Dosage. Genome-Wide Association Study. Polymorphism, Single Nucleotide. Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics. Twins, Monozygotic

  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Blood. 2010 Apr 29;115(17):3424-5 [20430963.001]
  • (PMID = 20061556.001).
  • [ISSN] 1528-0020
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] eng
  • [Grant] United Kingdom / Cancer Research UK / /
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Twin Study
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Core Binding Factor Alpha 2 Subunit; 0 / Oncogene Proteins, Fusion; 0 / TEL-AML1 fusion protein
  •  go-up   go-down


60. Mody R, Li S, Dover DC, Sallan S, Leisenring W, Oeffinger KC, Yasui Y, Robison LL, Neglia JP: Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood; 2008 Jun 15;111(12):5515-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
  • Survivors of childhood acute lymphoblastic leukemia (ALL) are at risk for late effects of cancer therapy.
  • Recurrent ALL (n = 483) and second neoplasms (SNs; n = 89) were the major causes of death.
  • Long-term survivors of childhood ALL exhibit excess mortality and morbidity.
  • Survivors who received radiation therapy as part of their treatment or had a leukemia relapse are at greatest risk for adverse outcomes.

  • Genetic Alliance. consumer health - Childhood Cancer.
  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia.
  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia, Childhood.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2006 Aug 20;24(24):3858-64 [16921038.001]
  • [Cites] J Clin Epidemiol. 2004 Sep;57(9):933-44 [15504636.001]
  • [Cites] Cancer. 2006 Sep 15;107(6):1303-12 [16894525.001]
  • [Cites] N Engl J Med. 2006 Oct 12;355(15):1572-82 [17035650.001]
  • [Cites] J Clin Oncol. 2006 Nov 20;24(33):5277-82 [17088567.001]
  • [Cites] Pediatr Blood Cancer. 2007 Apr;48(4):460-7 [16767717.001]
  • [Cites] J Pediatr. 2007 Apr;150(4):370-5, 375.e1 [17382112.001]
  • [Cites] Pediatr Blood Cancer. 2007 Jul;49(1):65-73 [16628558.001]
  • [Cites] Pediatr Blood Cancer. 2007 Jul;49(1):47-51 [16755550.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1356-63 [17627001.001]
  • [Cites] Am J Obstet Gynecol. 2002 Oct;187(4):1070-80 [12389007.001]
  • [Cites] Cancer. 2002 Dec 1;95(11):2431-41 [12436452.001]
  • [Cites] Cancer. 2000 Apr 1;88(7):1687-95 [10738228.001]
  • [Cites] Blood. 2000 May 1;95(9):2770-5 [10779419.001]
  • [Cites] Blood. 2000 Jun 1;95(11):3310-22 [10828010.001]
  • [Cites] J Natl Cancer Inst. 2001 Apr 18;93(8):618-29 [11309438.001]
  • [Cites] J Clin Oncol. 2001 Jul 1;19(13):3163-72 [11432882.001]
  • [Cites] J Clin Oncol. 2001 Jul 1;19(13):3173-81 [11432883.001]
  • [Cites] Cancer. 2001 Oct 1;92(7):1977-83 [11745273.001]
  • [Cites] Med Pediatr Oncol. 2002 Apr;38(4):229-39 [11920786.001]
  • [Cites] Blood. 2002 Jun 15;99(12):4257-64 [12036851.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Jul;87(7):3136-41 [12107213.001]
  • [Cites] Cancer. 1986 Jul 15;58(2 Suppl):598-602 [3719551.001]
  • [Cites] N Engl J Med. 1987 Sep 3;317(10):588-93 [3475572.001]
  • [Cites] JAMA. 1989 Nov 17;262(19):2693-9 [2810602.001]
  • [Cites] Cancer. 1991 Jan 1;67(1):206-13 [1985719.001]
  • [Cites] Am J Pediatr Hematol Oncol. 1990 Winter;12(4):454-61 [2285126.001]
  • [Cites] Acta Paediatr Scand. 1991 Dec;80(12):1220-8 [1785295.001]
  • [Cites] J Clin Oncol. 1992 Sep;10(9):1397-406 [1517782.001]
  • [Cites] Am J Pediatr Hematol Oncol. 1994 May;16(2):143-52 [8166367.001]
  • [Cites] JAMA. 1994 Nov 9;272(18):1427-32 [7933424.001]
  • [Cites] Child Care Health Dev. 1994 Sep-Oct;20(5):309-22 [7988001.001]
  • [Cites] J Dev Behav Pediatr. 1994 Oct;15(5):353-66 [7868704.001]
  • [Cites] Cancer. 1995 Apr 15;75(8):2186-95 [7697611.001]
  • [Cites] N Engl J Med. 1995 Jun 15;332(24):1618-30 [7753142.001]
  • [Cites] Arch Dis Child. 1995 Aug;73(2):136-40 [7574857.001]
  • [Cites] J Child Psychol Psychiatry. 1996 Jul;37(5):597-607 [8807440.001]
  • [Cites] Oncology (Williston Park). 1997 Feb;11(2):259-64; discussion 264-5 [9057179.001]
  • [Cites] J Clin Oncol. 1997 Jun;15(6):2205-13 [9196132.001]
  • [Cites] Pediatr Clin North Am. 1997 Aug;44(4):1021-42 [9286298.001]
  • [Cites] J Clin Oncol. 1998 Aug;16(8):2848-53 [9704738.001]
  • [Cites] N Engl J Med. 1998 Aug 27;339(9):605-15 [9718381.001]
  • [Cites] Eur J Cancer. 1998 Apr;34(5):694-8 [9713276.001]
  • [Cites] Curr Probl Pediatr. 1998 Oct;28(9):273-97 [9794096.001]
  • [Cites] Stat Med. 1999 Mar 30;18(6):695-706 [10204198.001]
  • [Cites] Br J Cancer. 2004 Nov 29;91(11):1905-10 [15534607.001]
  • [Cites] Lancet. 2005 Jun 11-17;365(9476):2014-23 [15950715.001]
  • [Cites] J Clin Oncol. 2005 Dec 20;23(36):9187-97 [16361621.001]
  • [Cites] J Clin Oncol. 2006 Jun 1;24(16):2536-43 [16735706.001]
  • [Cites] J Natl Cancer Inst. 2006 Jul 5;98(13):890-6 [16818852.001]
  • [Cites] Turk J Pediatr. 2006 Apr-Jun;48(2):101-4 [16848106.001]
  • [Cites] Acta Paediatr. 2006 Aug;95(8):922-8 [16882563.001]
  • [Cites] Eur J Cancer. 2003 Feb;39(3):359-65 [12565989.001]
  • [Cites] Cancer. 2003 Feb 15;97(4):1115-26 [12569614.001]
  • [Cites] J Clin Oncol. 2003 Apr 1;21(7):1359-65 [12663727.001]
  • [Cites] Cancer. 2003 May 15;97(10):2554-64 [12733155.001]
  • [Cites] N Engl J Med. 2003 Aug 14;349(7):640-9 [12917300.001]
  • [Cites] JAMA. 2003 Sep 24;290(12):1583-92 [14506117.001]
  • [Cites] Ann Intern Med. 2004 Oct 19;141(8):590-7 [15492338.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Sep;91(9):3494-8 [16822820.001]
  • (PMID = 18334672.001).
  • [ISSN] 1528-0020
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] ENG
  • [Grant] United States / PHS HHS / / U24 55727; United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2424150
  •  go-up   go-down


61. Seif AE, Barrett DM, Milone M, Brown VI, Grupp SA, Reid GS: Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses. Blood; 2009 Sep 17;114(12):2459-66
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses.
  • Acute lymphoblastic leukemia (ALL) is the most common childhood cancer and remains a major cause of mortality in children with recurrent disease and in adults.
  • Despite observed graft-versus-leukemia effects after stem cell transplantation, successful immune therapies for ALL have proven elusive.
  • CpG ODN induced early killing of leukemia by innate immune effectors both in vitro and in vivo.
  • Mice were treated with CpG ODN starting 7 days after injection with leukemia to mimic a minimal residual disease state and achieved T cell-dependent remissions of more than 6 months.
  • In addition, mice in remission after CpG ODN treatment were protected from leukemia rechallenge, and adoptive transfer of T cells from mice in remission conferred protection against leukemia growth.

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 2004 Aug 15;64(16):5850-60 [15313929.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15113-8 [14657335.001]
  • [Cites] Blood. 1996 Jul 1;88(1):41-8 [8704200.001]
  • [Cites] Blood. 1998 Jul 1;92(1):273-82 [9639527.001]
  • [Cites] Blood. 1998 Nov 15;92(10):3529-36 [9808544.001]
  • [Cites] Leukemia. 2005 Jan;19(1):44-8 [15496974.001]
  • [Cites] Exp Hematol. 2005 Mar;33(3):286-94 [15730852.001]
  • [Cites] Exp Hematol. 2005 Mar;33(3):344-52 [15730858.001]
  • [Cites] Blood. 2005 May 1;105(9):3641-7 [15650062.001]
  • [Cites] Br J Haematol. 2005 Jul;130(1):67-75 [15982346.001]
  • [Cites] Blood. 2006 Feb 15;107(4):1332-41 [16249392.001]
  • [Cites] Leukemia. 2006 Apr;20(4):645-9 [16498391.001]
  • [Cites] Leukemia. 2007 Jan;21(1):110-20 [17024114.001]
  • [Cites] Blood. 2007 Feb 1;109(3):926-35 [17003380.001]
  • [Cites] Blood. 2007 Mar 1;109(5):2008-13 [17068155.001]
  • [Cites] Immunology. 2007 Mar;120(3):412-23 [17163960.001]
  • [Cites] Nat Med. 2007 Mar;13(3):354-60 [17334371.001]
  • [Cites] Environ Sci Technol. 2007 Mar 15;41(6):2064-8 [17410806.001]
  • [Cites] J Clin Invest. 2007 May;117(5):1184-94 [17476348.001]
  • [Cites] J Clin Invest. 2008 Mar;118(3):1165-75 [18259609.001]
  • [Cites] FASEB J. 2008 Jun;22(6):2053-63 [18180331.001]
  • [Cites] Ann Hematol. 2008 Sep;87(9):701-8 [18437383.001]
  • [Cites] Blood. 2008 Sep 15;112(6):2205-13 [18591383.001]
  • [Cites] Leukemia. 2008 Nov;22(11):2070-9 [18633431.001]
  • [Cites] Blood. 2009 Apr 9;113(15):3546-52 [18941113.001]
  • [Cites] J Cell Mol Med. 2009 Aug;13(8B):1962-76 [18624776.001]
  • [Cites] Blood. 2000 Mar 1;95(5):1572-9 [10688810.001]
  • [Cites] Blood. 2000 Jun 1;95(11):3323-7 [10828011.001]
  • [Cites] Cytokine. 2001 Jan 7;13(1):39-50 [11145841.001]
  • [Cites] Br J Haematol. 2000 Dec;111(4):1130-7 [11167752.001]
  • [Cites] Cancer Res. 2001 Apr 15;61(8):3399-405 [11309299.001]
  • [Cites] Blood. 2002 May 1;99(9):3151-7 [11964277.001]
  • [Cites] Biol Blood Marrow Transplant. 2002;8(4):213-20 [12014810.001]
  • [Cites] Leukemia. 2002 Oct;16(10):2046-54 [12357356.001]
  • [Cites] Clin Cancer Res. 2003 Jan;9(1):76-83 [12538454.001]
  • [Cites] J Immunol. 2003 Jul 1;171(1):166-74 [12816995.001]
  • [Cites] Leukemia. 2003 Aug;17(8):1566-72 [12886244.001]
  • [Cites] Methods. 2003 Oct;31(2):135-42 [12957571.001]
  • [Cites] Trends Biotechnol. 1991 Apr;9(4):109-13 [1367388.001]
  • (PMID = 19636062.001).
  • [ISSN] 1528-0020
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / K12 CA076931; United States / NCI NIH HHS / CA / 2K12CA076931-11; United States / NCI NIH HHS / CA / T32 CA009615; United States / NCI NIH HHS / CA / R03-CA123554; United States / NCI NIH HHS / CA / R03 CA123554
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CPG-oligonucleotide; 0 / Oligodeoxyribonucleotides
  • [Other-IDs] NLM/ PMC2746473
  •  go-up   go-down


62. Rawat J, Rashid KA, Kanojia RP, Kureel SN, Tandon RK: Diagnosis and management of congenital bladder diverticulum in infancy and childhood: experience with nine cases at a tertiary health center in a developing country. Int Urol Nephrol; 2009;41(2):237-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis and management of congenital bladder diverticulum in infancy and childhood: experience with nine cases at a tertiary health center in a developing country.
  • OBJECTIVES: The purpose of the study is to present the authors' clinical and surgical experience with congenital bladder diverticula in nine pediatric patients at a developing world tertiary care center.
  • CONCLUSION: Pediatric patients with recurrent urinary tract infections and voiding dysfunction should always be evaluated for congenital bladder diverticulum.

  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 1994 Mar;190(3):695-7 [8115613.001]
  • [Cites] Urology. 2007 Nov;70(5):984-8 [18068458.001]
  • [Cites] J Urol. 1972 Jun;107(6):966-8 [4624518.001]
  • [Cites] J Urol. 1961 Oct;86:390-9 [14450230.001]
  • [Cites] Urology. 1985 Mar;25(3):273-6 [3919483.001]
  • [Cites] J Urol. 1981 Aug;126(2):262-4 [7265378.001]
  • [Cites] J Urol. 1976 Aug;116(2):234-6 [820878.001]
  • [Cites] J Urol. 1984 Dec;132(6):1186-8 [6438352.001]
  • [Cites] J Urol. 1999 Dec;162(6):2112-3 [10569597.001]
  • [Cites] J Urol. 1979 Sep;122(3):415 [112263.001]
  • [Cites] J Pediatr Surg. 1997 May;32(5):782-4 [9165480.001]
  • [Cites] J Urol. 2004 Oct;172(4 Pt 2):1614-6 [15371773.001]
  • [Cites] Surg Endosc. 2000 May;14(5):501 [11252187.001]
  • [Cites] Pediatr Radiol. 1979 Feb 26;8(1):29-31 [107508.001]
  • [Cites] J Urol. 1980 Dec;124(6):791-6 [6777506.001]
  • [Cites] J Pediatr Surg. 2005 Apr;40(4):701-3 [15852283.001]
  • [Cites] Int Urol Nephrol. 2005;37(3):473-5 [16307322.001]
  • [Cites] J Urol. 2004 Nov;172(5 Pt 1):1977-9 [15540770.001]
  • [Cites] J Pediatr Surg. 1989 Nov;24(11):1184-6 [2509670.001]
  • [Cites] Fetal Diagn Ther. 1999 Sep-Oct;14 (5):301-5 [10529575.001]
  • [Cites] J Urol. 2002 Sep;168(3):1135-7 [12187254.001]
  • [Cites] Urology. 1995 Apr;45(4):664-6 [7716849.001]
  • (PMID = 18704744.001).
  • [ISSN] 1573-2584
  • [Journal-full-title] International urology and nephrology
  • [ISO-abbreviation] Int Urol Nephrol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


63. Mandhan P, Memon A, Memon AS: Congenital hernias of the diaphragm in children. J Ayub Med Coll Abbottabad; 2007 Apr-Jun;19(2):37-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In other types of CDHs, the mean age at presentation was 39 (18-60) months and they mostly presented with recurrent respiratory tract infections and/or mild gastrointestinal symptoms.
  • CONCLUSION: The different types of CDHs presented from neonatal age to later childhood with distinct symptoms.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18183717.001).
  • [ISSN] 1025-9589
  • [Journal-full-title] Journal of Ayub Medical College, Abbottabad : JAMC
  • [ISO-abbreviation] J Ayub Med Coll Abbottabad
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


64. Foreman NK, Schissel D, Le T, Strain J, Fleitz J, Quinones R, Giller R: A study of sequential high dose cyclophosphamide and high dose carboplatin with peripheral stem-cell rescue in resistant or recurrent pediatric brain tumors. J Neurooncol; 2005 Jan;71(2):181-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A study of sequential high dose cyclophosphamide and high dose carboplatin with peripheral stem-cell rescue in resistant or recurrent pediatric brain tumors.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1986 Jan 15;57(2):222-5 [3510700.001]
  • [Cites] J Neurosurg. 1998 Jul;89(1):52-9 [9647172.001]
  • [Cites] Am J Pediatr Hematol Oncol. 1990 Fall;12(3):297-300 [2173440.001]
  • [Cites] J Neurosurg. 1990 Apr;72(4):572-82 [2319316.001]
  • [Cites] J Neurooncol. 1998 Mar;37(1):67-73 [9525840.001]
  • [Cites] J Clin Oncol. 2003 Sep 1;21(17):3255-61 [12947060.001]
  • [Cites] Bone Marrow Transplant. 1992 Nov;10 (5):457-62 [1464010.001]
  • [Cites] Cancer Res. 1984 Apr;44(4):1693-7 [6367971.001]
  • [Cites] J Clin Oncol. 1997 May;15(5):1814-23 [9164190.001]
  • [Cites] Bone Marrow Transplant. 2000 Jul;26(2):153-60 [10918425.001]
  • [Cites] Oncologist. 1996;1(6):381-393 [10388020.001]
  • [Cites] Cancer Chemother Pharmacol. 1982;9(3):140-7 [6761010.001]
  • [Cites] J Clin Oncol. 1996 Feb;14(2):382-8 [8636747.001]
  • [Cites] Br J Cancer. 2003 Sep 1;89(5):787-94 [12942106.001]
  • [Cites] Bone Marrow Transplant. 1992 Apr;9(4):227-33 [1534708.001]
  • [Cites] Cancer Treat Rep. 1984 Sep;68(9):1103-14 [6383605.001]
  • [Cites] J Clin Oncol. 1989 May;7(5):651-61 [2651580.001]
  • [Cites] J Clin Oncol. 1996 Sep;14(9):2495-503 [8823328.001]
  • [Cites] J Clin Oncol. 1998 Jul;16(7):2426-34 [9667260.001]
  • [Cites] J Clin Oncol. 1999 Jul;17(7):2127-36 [10561268.001]
  • [Cites] J Clin Oncol. 1987 Mar;5(3):459-63 [3546620.001]
  • [Cites] Neurosurgery. 1995 Dec;37(6):1056-68 [8584145.001]
  • [Cites] J Clin Oncol. 1989 Jun;7(6):754-60 [2715805.001]
  • [Cites] J Clin Oncol. 2003 Apr 15;21(8):1581-91 [12697884.001]
  • [Cites] J Clin Oncol. 1992 Apr;10(4):520-8 [1548516.001]
  • [Cites] J Clin Oncol. 2003 Sep 1;21(17):3183-5 [12860965.001]
  • [Cites] Cancer Res. 1984 Nov;44(11):5432-8 [6386150.001]
  • [Cites] Cancer Res. 1983 Sep;43(9):4470-3 [6347373.001]
  • [Cites] J Neurooncol. 1996 Jul;29(1):69-74 [8817417.001]
  • [Cites] Cancer. 1990 Dec 15;66(12):2465-9 [2249186.001]
  • [Cites] J Clin Oncol. 1997 Oct;15(10):3258-65 [9336363.001]
  • (PMID = 15690136.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Antineoplastic Agents, Alkylating; 8N3DW7272P / Cyclophosphamide; BG3F62OND5 / Carboplatin
  •  go-up   go-down


65. Milliner DS: The primary hyperoxalurias: an algorithm for diagnosis. Am J Nephrol; 2005 Mar-Apr;25(2):154-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Patients with stones or nephrocalcinosis in childhood, recurrent calcium oxalate stones in adulthood, or renal insufficiency associated with stones or nephrocalcinosis should be evaluated for PH.

  • SciCrunch. Clinical Genomic Database: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2005 S. Karger AG, Basel
  • (PMID = 15855742.001).
  • [ISSN] 0250-8095
  • [Journal-full-title] American journal of nephrology
  • [ISO-abbreviation] Am. J. Nephrol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 52
  •  go-up   go-down


66. Domínguez Hinarejos C, Bonillo García MA, Alapont Alacreu JM, Serrano Durbá A, Estornell Moragues F, García Ibarra F: [Assesmment urethrorrhagia in childhood]. Actas Urol Esp; 2007 Jan;31(1):29-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Assesmment urethrorrhagia in childhood].
  • CONCLUSIONS: Urethrorrhagia in childhood is a benign condition in most cases, which is almost always cured spontaneously during the first 2 years of follow-up.
  • Radiological studies as well as endoscopic procedures are unnecessary in the early management of these patients thus being relegated to recurrent or persistent bleeding.

  • MedlinePlus Health Information. consumer health - Urethral Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17410983.001).
  • [ISSN] 0210-4806
  • [Journal-full-title] Actas urologicas españolas
  • [ISO-abbreviation] Actas Urol Esp
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


67. Gower WA, Collaco JM, Mogayzel PJ Jr: Lung function and late pulmonary complications among survivors of hematopoietic stem cell transplantation during childhood. Paediatr Respir Rev; 2010 Jun;11(2):115-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lung function and late pulmonary complications among survivors of hematopoietic stem cell transplantation during childhood.
  • Young children, whose lungs are still developing and growing, may be especially susceptible to the insults of irradiation, drug toxicities, and recurrent infections associated with immunosuppression.
  • The pulmonologist should be familiar with common patterns seen on PFT in recipients of HSCT during childhood.
  • In this review, we describe the findings in studies which have examined lung function over time in patients who underwent HSCT during childhood.

  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20416548.001).
  • [ISSN] 1526-0550
  • [Journal-full-title] Paediatric respiratory reviews
  • [ISO-abbreviation] Paediatr Respir Rev
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Immunosuppressive Agents
  • [Number-of-references] 90
  •  go-up   go-down


68. Ozer S, Hallioğlu O, Ozkutlu S, Celiker A, Alehan D, Karagöz T: Childhood acute rheumatic fever in Ankara, Turkey. Turk J Pediatr; 2005 Apr-Jun;47(2):120-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Childhood acute rheumatic fever in Ankara, Turkey.
  • Patients with acute rheumatic fever (ARF) admitted to a tertiary hospital in Ankara between January 1999 and July 2002 were studied cross-sectionally to verify the clinical profile and were followed during the acute period.
  • The observation that 8.5% of the attacks were recurrent reaffirms the need for more effective secondary prevention programs.
  • [MeSH-minor] Acute Disease. Adolescent. Adult. Arthritis / etiology. Child. Cross-Sectional Studies. Female. Humans. Male. Recurrence. Turkey / epidemiology

  • Genetic Alliance. consumer health - Rheumatic Fever.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16052850.001).
  • [ISSN] 0041-4301
  • [Journal-full-title] The Turkish journal of pediatrics
  • [ISO-abbreviation] Turk. J. Pediatr.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


69. Levin-Iaina N, Dinour D, Romero L, Ron R, Brady RL, Cramer SD, Holtzman EJ: Late diagnosis of primary hyperoxaluria type 2 in the adult: effect of a novel mutation in GRHPR gene on enzymatic activity and molecular modeling. J Urol; 2009 May;181(5):2146-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary hyperoxaluria type 2 is a rare autosomal recessive disease caused by mutations in the GRHPR gene, leading to an accumulation of oxalate and L-glycerate with recurrent kidney stone formation and nephrocalcinosis, and the later development of renal failure and systemic oxalate depositions.
  • CONCLUSIONS: Primary hyperoxaluria type 2 should be considered in patients at adult stone clinics who have had a history of nephrolithiasis since childhood, especially in those with consanguineous parents.


70. Helgeland H, Sandvik L, Mathiesen KS, Kristensen H: Childhood predictors of recurrent abdominal pain in adolescence: A 13-year population-based prospective study. J Psychosom Res; 2010 Apr;68(4):359-67
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Childhood predictors of recurrent abdominal pain in adolescence: A 13-year population-based prospective study.
  • OBJECTIVE: To investigate maternal and child emotional symptoms, physical health problems, and negative life events measured at children's age 18 months and 12 years as potential predictors for self-reported recurrent abdominal pain (RAP) in adolescents (14 years).
  • CONCLUSIONS: This is the first cohort study that finds maternal psychological distress in early childhood to predict RAP in their offspring 13 years later.

  • MedlinePlus Health Information. consumer health - Abdominal Pain.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20307703.001).
  • [ISSN] 1879-1360
  • [Journal-full-title] Journal of psychosomatic research
  • [ISO-abbreviation] J Psychosom Res
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


71. McElhinney DB, Lock JE, Keane JF, Moran AM, Colan SD: Left heart growth, function, and reintervention after balloon aortic valvuloplasty for neonatal aortic stenosis. Circulation; 2005 Feb 1;111(4):451-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Reintervention for residual/recurrent AS or iatrogenic AR is relatively common, particularly during the first year after BAVP, but aortic valve replacement during early childhood is seldom necessary.

  • MedlinePlus Health Information. consumer health - After Surgery.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15687133.001).
  • [ISSN] 1524-4539
  • [Journal-full-title] Circulation
  • [ISO-abbreviation] Circulation
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 19
  •  go-up   go-down


72. Schuetz C, Prieur AM, Quartier P: Sicca syndrome and salivary gland infiltration in children with autoimmune disorders: when can we diagnose Sjögren syndrome? Clin Exp Rheumatol; 2010 May-Jun;28(3):434-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: To analyse the initial presentation and outcome of children with a diagnosis of childhood-onset Sjögren's syndrome (SS) in a paediatric referral care center.
  • RESULTS: Eight patients had a diagnosis of SS in childhood and were followed for up to 14 years.
  • Sicca syndrome as a presenting symptom occurred in only 2/8 of children, recurrent parotid swelling in 3/8; whereas anti-SSA/SSB antibodies and typical salivary-gland histology were found in 6/8 patients.
  • CONCLUSIONS: Childhood-onset SS is an heterogeneous disease in its presentation and outcome.


73. Lugtenberg D, Kleefstra T, Oudakker AR, Nillesen WM, Yntema HG, Tzschach A, Raynaud M, Rating D, Journel H, Chelly J, Goizet C, Lacombe D, Pedespan JM, Echenne B, Tariverdian G, O'Rourke D, King MD, Green A, van Kogelenberg M, Van Esch H, Gecz J, Hamel BC, van Bokhoven H, de Brouwer AP: Structural variation in Xq28: MECP2 duplications in 1% of patients with unexplained XLMR and in 2% of male patients with severe encephalopathy. Eur J Hum Genet; 2009 Apr;17(4):444-53
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Duplications in Xq28 involving MECP2 have been described in patients with severe mental retardation, infantile hypotonia, progressive spasticity, and recurrent infections.
  • Moderate to severe mental retardation and childhood hypotonia was noted in all patients.


74. Kahn JA: Vaccination as a prevention strategy for human papillomavirus-related diseases. J Adolesc Health; 2005 Dec;37(6 Suppl):S10-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Childhood vaccines have had an enormously beneficial impact on human health.
  • Moreover, low-risk HPV types 6 or 11 are responsible for approximately 90% of genital warts and almost all cases of recurrent respiratory papillomatosis.
  • Thus, a vaccine that could prevent HPV acquisition would have the potential to significantly reduce the incidence of both childhood and adult diseases.

  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16310136.001).
  • [ISSN] 1879-1972
  • [Journal-full-title] The Journal of adolescent health : official publication of the Society for Adolescent Medicine
  • [ISO-abbreviation] J Adolesc Health
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Viral Vaccines
  • [Number-of-references] 44
  •  go-up   go-down


75. Moss IR, Bélisle M, Laferrière A: Long-term recurrent hypoxia in developing rat attenuates respiratory responses to subsequent acute hypoxia. Pediatr Res; 2006 Apr;59(4 Pt 1):525-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term recurrent hypoxia in developing rat attenuates respiratory responses to subsequent acute hypoxia.
  • Whereas definitive treatment of pediatric conditions associated with hypoxemia reverses many pathologic symptoms, some physiologic dysfunctions appear to persist.
  • To investigate such effects in an animal model, male rats were exposed to FiO2 = 0.12 continuously for 7 h daily from postnatal day (p) 17 (representing early childhood) through p33 (representing adolescence), defined as recurrent hypoxia.
  • To control for early weaning on p15 (normal weaning = p21), male rats were weaned on either p15 or p21, raised in normoxia, and also tested for respiratory responsiveness to acute hypoxia.
  • After recurrent hypoxia, male rats displayed an attenuation of ventilation, frequency, and drive during hypoxia, and of all functions after hypoxia on both p35 and p47.
  • Thus, recurrent hypoxia produces long-lasting attenuation in respiratory responsiveness to subsequent acute hypoxia.
  • Such long-lasting attenuation, if present in humans, may diminish the protection of children with a history of recurrent hypoxemia against future hypoxic events.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16549523.001).
  • [ISSN] 0031-3998
  • [Journal-full-title] Pediatric research
  • [ISO-abbreviation] Pediatr. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


76. Barbetti F, Cobo-Vuilleumier N, Dionisi-Vici C, Toni S, Ciampalini P, Massa O, Rodriguez-Bada P, Colombo C, Lenzi L, Garcia-Gimeno MA, Bermudez-Silva FJ, Rodriguez de Fonseca F, Banin P, Aledo JC, Baixeras E, Sanz P, Cuesta-Muñoz AL: Opposite clinical phenotypes of glucokinase disease: Description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene. Mol Endocrinol; 2009 Dec;23(12):1983-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we present a novel glucokinase gene (GCK)-activating mutation (p.E442K) found in an infant with neonatal hypoglycemia (1.5 mmol/liter) and in two other family members suffering from recurrent hypoglycemic episodes in their childhood and adult life.

  • Andalusian Health Repository. Full Text from .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Diabetes. 2002 Apr;51(4):1240-6 [11916951.001]
  • [Cites] Eur J Endocrinol. 2008 Jul;159(1):27-34 [18450771.001]
  • [Cites] Diabetologia. 1999 Oct;42(10):1175-86 [10525657.001]
  • [Cites] Hum Mutat. 2003 Nov;22(5):353-62 [14517946.001]
  • [Cites] Diabetes. 2003 Nov;52(11):2854-60 [14578306.001]
  • [Cites] Nat Rev Drug Discov. 2009 May;8(5):399-416 [19373249.001]
  • [Cites] Mol Genet Metab. 2004 Apr;81 Suppl 1:S45-51 [15050973.001]
  • [Cites] N Engl J Med. 2001 May 24;344(21):1588-92 [11372010.001]
  • [Cites] Diabetologia. 1996 Mar;39(3):370-1 [8721788.001]
  • [Cites] Structure. 2004 Mar;12(3):429-38 [15016359.001]
  • [Cites] Endocr Rev. 2008 May;29(3):254-64 [18436708.001]
  • [Cites] Clin Chim Acta. 2004 Mar;341(1-2):23-6 [14967154.001]
  • [Cites] N Engl J Med. 1998 Jan 22;338(4):226-30 [9435328.001]
  • [Cites] Diabetologia. 2001 Jul;44(7):898-905 [11508276.001]
  • [Cites] Diabetes Care. 2009 Oct;32(10):1864-6 [19564454.001]
  • [Cites] Diabetes. 2009 Jun;58(6):1419-27 [19336674.001]
  • [Cites] J Clin Invest. 1994 Mar;93(3):1120-30 [8132752.001]
  • [Cites] Diabetes. 2004 Aug;53(8):2164-8 [15277402.001]
  • [Cites] Diabetologia. 2006 May;49(5):1106-8 [16502298.001]
  • [Cites] Diabetes. 2002 Dec;51 Suppl 3:S394-404 [12475782.001]
  • [Cites] Horm Metab Res. 2009 Apr;41(4):320-6 [19053014.001]
  • (PMID = 19884385.001).
  • [ISSN] 1944-9917
  • [Journal-full-title] Molecular endocrinology (Baltimore, Md.)
  • [ISO-abbreviation] Mol. Endocrinol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.1.2 / Glucokinase
  •  go-up   go-down


77. Baysal BE: A recurrent stop-codon mutation in succinate dehydrogenase subunit B gene in normal peripheral blood and childhood T-cell acute leukemia. PLoS One; 2007 May 09;2(5):e436
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A recurrent stop-codon mutation in succinate dehydrogenase subunit B gene in normal peripheral blood and childhood T-cell acute leukemia.
  • Here, I describe that succinate dehydrogenase (SDH; mitochondrial complex II) subunit B gene (SDHB) is somatically mutated at a cytidine residue in normal peripheral blood mononuclear cells (PBMCs) and T-cell acute leukemia.
  • Transcript sequence analyses in leukemic cell lines derived from monocyte, NK, T and B cells indicate that the mutational mechanism targeting SDHB is operational in T-cell acute leukemia.
  • Accordingly, substantial levels (more than 3%) of the mutant SDHB transcripts are detected in five of 20 primary childhood T-cell acute lymphoblastic leukemia (T-ALL) bone marrow samples, but in none of 20 B-ALL samples.
  • CONCLUSIONS: The identification of a recurrent, inactivating stop-codon mutation in the SDHB gene in normal blood cells suggests that SDHB is targeted by a cytidine deaminase enzyme.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Blood. 2004 Oct 15;104(8):2224-34 [15231578.001]
  • [Cites] Hum Genet. 2003 Aug;113(3):228-37 [12811540.001]
  • [Cites] Eur J Haematol. 1999 Sep;63(3):180-91 [10485273.001]
  • [Cites] Mol Cell Biol. 2004 Dec;24(24):10933-40 [15572694.001]
  • [Cites] Nat Rev Cancer. 2005 Nov;5(11):857-66 [16327764.001]
  • [Cites] BMC Med Genet. 2005;6:39 [16288654.001]
  • [Cites] Nat Rev Mol Cell Biol. 2006 Jun;7(6):415-25 [16723977.001]
  • [Cites] Cancer Res. 2006 Aug 1;66(15):7615-20 [16885361.001]
  • [Cites] Anal Biochem. 2007 Jan 1;360(1):84-91 [17107651.001]
  • [Cites] J Exp Med. 2007 Jan 22;204(1):7-10 [17190841.001]
  • [Cites] BMC Biol. 2007;5:12 [17376234.001]
  • [Cites] J Appl Physiol (1985). 2005 Feb;98(2):715-21 [15649883.001]
  • [Cites] Science. 2000 Feb 4;287(5454):848-51 [10657297.001]
  • [Cites] Nat Genet. 2000 Aug;25(4):375-6 [10932175.001]
  • [Cites] Am J Hum Genet. 2002 Jan;70(1):38-50 [11727199.001]
  • [Cites] Annu Rev Immunol. 2002;20:165-96 [11861601.001]
  • [Cites] J Med Genet. 2002 Mar;39(3):178-83 [11897817.001]
  • [Cites] Trends Genet. 2003 Apr;19(4):207-16 [12683974.001]
  • [Cites] Annu Rev Genet. 1990;24:305-26 [2088171.001]
  • (PMID = 17487275.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA98543; United States / NCI NIH HHS / CA / CA114766; United States / NCI NIH HHS / CA / U24 CA114766; United States / NCI NIH HHS / CA / U10 CA098543; United States / NCI NIH HHS / CA / CA11236
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Codon, Terminator; 0 / DNA Primers; 0 / RNA, Messenger; EC 1.3.99.1 / Succinate Dehydrogenase
  • [Other-IDs] NLM/ PMC1855983
  • [General-notes] NLM/ Original DateCompleted: 20070727
  •  go-up   go-down


78. Mourad S, Rajab M, Alameddine A, Fares M, Ziade F, Merhi BA: Hemoglobin level as a risk factor for lower respiratory tract infections in Lebanese children. N Am J Med Sci; 2010 Oct;2(10):461-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Pneumonia is the biggest single cause of childhood death under the age of 5 years, and anemia affects approximately 30% of infants and children all over the world.
  • History of recurrent chest infections was significantly higher in both anemic group and hospitalized cases compared to non-anemic group and healthy controls.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22558548.001).
  • [ISSN] 1947-2714
  • [Journal-full-title] North American journal of medical sciences
  • [ISO-abbreviation] N Am J Med Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3339108
  • [Keywords] NOTNLM ; Hemoglobin level / iron deficiency anemia / lower respiratory tract infection
  •  go-up   go-down


79. Teh SH, Pham TH, Lee A, Stavlo PL, Hanna AM, Moir C: Pancreatic pseudocyst in children: the impact of management strategies on outcome. J Pediatr Surg; 2006 Nov;41(11):1889-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Persistent pancreatic pseudocysts (PPs) are rare in childhood and management tends to be individualized.
  • The mean time to operation for the remaining 17 children (71%) was 13.1 weeks (range, 6-36 weeks), with indications for intervention including persistent/recurrent abdominal pain (17), failure to thrive (9), infected PP (1), and ruptured PP (1).

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17101365.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


80. Fox VL, Perros S, Jiang H, Goldsmith JD: Juvenile polyps: recurrence in patients with multiple and solitary polyps. Clin Gastroenterol Hepatol; 2010 Sep;8(9):795-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND & AIMS: Juvenile polyps are benign hamartomas with neoplastic potential that are the most frequent gastrointestinal polyp of childhood.
  • Most information about juvenile polyps in childhood comes from small published series that lack detailed outcome data.
  • CONCLUSIONS: Recurrent polyp formation is common in children with juvenile polyps and occurs in patients with multiple and solitary polyps.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20580940.001).
  • [ISSN] 1542-7714
  • [Journal-full-title] Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • [ISO-abbreviation] Clin. Gastroenterol. Hepatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


81. Bunn J, Thindwa M, Kerac M: Features associated with underlying HIV infection in severe acute childhood malnutrition: a cross sectional study. Malawi Med J; 2009 Sep;21(3):108-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Features associated with underlying HIV infection in severe acute childhood malnutrition: a cross sectional study.
  • INTRODUCTION: Up to half of all children presenting to Nutrition Rehabilitation Units (NRUs) in Malawi with severe acute malnutrition (SAM) are infected with HIV.
  • A history of recurrent respiratory infection (OR 9.6, 4.8-18.6), persistent fever, recent outpatient attendance, or hospital admission were also associated with HIV.
  • [MeSH-minor] Acute Disease. Body Weight. Child, Preschool. Cross-Sectional Studies. Diagnosis, Differential. Disease Progression. Female. Follow-Up Studies. Humans. Incidence. Infant. Malawi / epidemiology. Male. Prognosis. Retrospective Studies


82. Sherman J, Thompson GB, Lteif A, Schwenk WF 2nd, van Heerden J, Farley DR, Kumar S, Zimmerman D, Churchward M, Grant CS: Surgical management of Graves disease in childhood and adolescence: an institutional experience. Surgery; 2006 Dec;140(6):1056-61; discussion 1061-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical management of Graves disease in childhood and adolescence: an institutional experience.
  • To evaluate the safety and efficacy of operative therapy, we updated our operative experience with pediatric Graves disease at a single tertiary care center.
  • Operative morbidities were transient and included hypoparathyroidism (6%) and recurrent laryngeal nerve neuropraxia (1%).
  • Three (4%) patients who underwent subtotal thyroidectomy developed recurrent hyperthyroidism; all were treated successfully with radioiodine ablation.

  • Genetic Alliance. consumer health - Graves' Disease.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17188157.001).
  • [ISSN] 0039-6060
  • [Journal-full-title] Surgery
  • [ISO-abbreviation] Surgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


83. Kaszper E, Hanzély Z, Szende B, Dabasi G, Garami M, Schuler D, Hauser P: [Examination of somatostatin receptor expression in recurrent childhood medulloblastomas]. Magy Onkol; 2008 Dec;52(4):351-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Examination of somatostatin receptor expression in recurrent childhood medulloblastomas].
  • Medulloblastoma is the most common malignant pediatric central nervous system tumor.
  • The primary medulloblastoma expresses somatostatin receptor-2 (SSTR-2), but so far we had no experience about the receptor status in recurrent tumors.
  • The presence of SSTR-2 may have an important role in the early detection and treatment of recurrent medulloblastomas.
  • Our aim was to examine the state of SSTR-2 expression in recurrent childhood medulloblastomas.
  • We examined SSTR-2 expression by immunohistochemistry in primary and recurrent medulloblastoma samples of ten children treated with recurrent medulloblastoma at Semmelweis University, Departments of Pediatrics, between 1998 and 2004.
  • All primary and recurrent tumors have been operated at the National Institute of Neurosurgery.
  • We examined the intensity and the percentage of SSTR-2-positive tumor cells in the primary and recurrent tumor samples.
  • All primary tumors were receptor-positive and SSTR-2 was also expressed in all recurrent medulloblastomas.
  • As a conclusion, SSTR-2-positive recurrent tumors can be detected early by Octreoscan imaging, and the presence of SSTR-2 establishes the opportunity of applying somatostatin analogues (octreotide) in the treatment of recurrent childhood medulloblastoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19068462.001).
  • [ISSN] 0025-0244
  • [Journal-full-title] Magyar onkologia
  • [ISO-abbreviation] Magy Onkol
  • [Language] hun
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Hungary
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; 0 / Biomarkers, Tumor; 0 / Indium Radioisotopes; 0 / Receptors, Somatostatin; 0 / somatostatin receptor 2; 51110-01-1 / Somatostatin; G083B71P98 / pentetreotide; RWM8CCW8GP / Octreotide
  •  go-up   go-down


84. Bacon CJ, Hall DB, Stephenson TJ, Campbell MJ: How common is repeat sudden infant death syndrome? Arch Dis Child; 2008 Apr;93(4):323-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We examine eight studies of recurrent SIDS published in English since 1970.


85. Satoh S, Itoh C, Nakamura N: [A case of frosted branch angiitis associated with retinal vein occlusion as a complication of familial Mediterranean fever]. Nippon Ganka Gakkai Zasshi; 2010 Jul;114(7):621-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Familial Mediterranean fever (FMF) is characterized by recurrent episodes of fever and serositis caused by autosomal recessive inheritance MEFV gene mutations.
  • Fever, abdominal pain and chest pain were continued from childhood.

  • Genetic Alliance. consumer health - Familial Mediterranean fever.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20681258.001).
  • [ISSN] 0029-0203
  • [Journal-full-title] Nippon Ganka Gakkai zasshi
  • [ISO-abbreviation] Nippon Ganka Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


86. Boogaard R, Huijsmans SH, Pijnenburg MW, Tiddens HA, de Jongste JC, Merkus PJ: Tracheomalacia and bronchomalacia in children: incidence and patient characteristics. Chest; 2005 Nov;128(5):3391-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Severe airway malacia or malacia associated with specific syndromes is usually recognized and diagnosed early in infancy, but information about clinical features of children with primary malacia, often diagnosed only later in childhood, is scarce.
  • METHODS: We analyzed all flexible bronchoscopies performed between 1997 and 2004 in the Sophia Children's Hospital, summarized clinical features of children with primary airway malacia, estimated the incidence of primary airway malacia, and calculated the predictive value of a clinical diagnosis of airway malacia by pediatric pulmonologists.
  • When pediatric pulmonologists expected to find airway malacia (based on symptoms, history, and lung function) prior to bronchoscopy, this was correct in 74% of the cases.
  • We recommend bronchoscopy in patients with impaired exercise tolerance, recurrent lower airways infection, and therapy-resistant, irreversible, and/or atypical asthma to rule out airway malacia.


87. Rau R, Brown P: Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity. Hematol Oncol; 2009 Dec;27(4):171-81
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.
  • Somatic mutations in exon 12 of the NPM gene (NPM1) are the most frequent genetic abnormality in adult acute myeloid leukaemia (AML), found in approximately 35% of all cases and up to 60% of patients with normal karyotype (NK) AML.
  • NPMc+ AML is seen predominantly in patients with a NK and is essentially mutually exclusive of recurrent chromosomal translocations.

  • MedlinePlus Health Information. consumer health - Acute Myeloid Leukemia.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 John Wiley & Sons, Ltd.
  • [Cites] Leukemia. 2007 Jul;21(7):1564-6 [17410190.001]
  • [Cites] Leukemia. 2007 Jul;21(7):1566-70 [17443224.001]
  • [Cites] Cancer Res. 2007 Jul 1;67(13):6230-7 [17616680.001]
  • [Cites] Blood. 2007 Aug 1;110(3):979-85 [17440048.001]
  • [Cites] Leukemia. 2007 Sep;21(9):2000-9 [17597811.001]
  • [Cites] Int J Hematol. 2007 Aug;86(2):143-6 [17875528.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15805-10 [17890317.001]
  • [Cites] Leukemia. 2008 Jan;22(1):195-8 [17637812.001]
  • [Cites] J Biol Chem. 2008 Feb 29;283(9):5728-37 [18165222.001]
  • [Cites] Blood. 2008 Mar 1;111(5):2776-84 [17957027.001]
  • [Cites] Leukemia. 2008 Jun;22(6):1234-40 [18401421.001]
  • [Cites] Blood. 1996 Feb 1;87(3):882-6 [8562957.001]
  • [Cites] Oncogene. 1996 Jan 18;12(2):265-75 [8570204.001]
  • [Cites] J Pathol. 1996 Jan;178(1):48-52 [8778315.001]
  • [Cites] Mol Cell Biol. 1997 Apr;17(4):2312-25 [9121481.001]
  • [Cites] Cell. 1997 Nov 28;91(5):649-59 [9393858.001]
  • [Cites] J Soc Gynecol Investig. 1997 Nov-Dec;4(6):298-304 [9408885.001]
  • [Cites] FEBS Lett. 1997 Dec 22;420(1):25-7 [9450543.001]
  • [Cites] Nat Cell Biol. 1999 May;1(1):20-6 [10559859.001]
  • [Cites] Cell. 2000 Sep 29;103(1):127-40 [11051553.001]
  • [Cites] Curr Opin Hematol. 2001 Jul;8(4):189-91 [11561153.001]
  • [Cites] FEBS Lett. 2001 Oct 12;506(3):272-6 [11602260.001]
  • [Cites] Nat Genet. 2002 Jan;30(1):41-7 [11731795.001]
  • [Cites] Blood. 2002 Jan 15;99(2):409-26 [11781220.001]
  • [Cites] Leukemia. 2002 Jun;16(6):1053-68 [12040437.001]
  • [Cites] Nat Cell Biol. 2002 Jul;4(7):529-33 [12080348.001]
  • [Cites] Blood. 2002 Sep 1;100(5):1532-42 [12176867.001]
  • [Cites] Biosci Biotechnol Biochem. 2002 Oct;66(10):2239-42 [12450141.001]
  • [Cites] Mol Cell. 2003 Feb;11(2):415-24 [12620229.001]
  • [Cites] Hematol J. 2003;4(1):31-40 [12692518.001]
  • [Cites] Leukemia. 2003 Sep;17(9):1738-52 [12970773.001]
  • [Cites] Mol Cell Biol. 2004 Feb;24(3):985-96 [14729947.001]
  • [Cites] Science. 2004 Apr 23;304(5670):594-6 [15105502.001]
  • [Cites] Cancer Cell. 2004 May;5(5):465-75 [15144954.001]
  • [Cites] Genes Dev. 2004 Aug 1;18(15):1862-74 [15289458.001]
  • [Cites] J Biol Chem. 2004 Aug 20;279(34):35726-34 [15190079.001]
  • [Cites] FEBS Lett. 2004 Sep 24;575(1-3):112-8 [15388344.001]
  • [Cites] Blood. 2008 Mar 1;111(5):2527-37 [17965322.001]
  • [Cites] Haematologica. 2008 Mar;93(3):439-42 [18268276.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3945-50 [18308931.001]
  • [Cites] Leuk Lymphoma. 2007 Nov;48(11):2141-4 [17990177.001]
  • [Cites] Blood. 2008 Apr 1;111(7):3859-62 [18212245.001]
  • [Cites] Oncogene. 2008 Apr 10;27(17):2382-9 [17968318.001]
  • [Cites] Blood. 2008 May 15;111(10):5078-85 [18337557.001]
  • [Cites] Leukemia. 2008 May;22(5):1075-8 [17972951.001]
  • [Cites] Curr Opin Hematol. 2008 Jul;15(4):352-8 [18536574.001]
  • [Cites] Leukemia. 2008 Jun;22(6):1285-9 [18059485.001]
  • [Cites] Mol Cell Biol. 2004 Nov;24(21):9327-38 [15485902.001]
  • [Cites] Cell. 1989 Feb 10;56(3):379-90 [2914325.001]
  • [Cites] J Biol Chem. 1990 Oct 25;265(30):18227-33 [2211699.001]
  • [Cites] Cancer Res. 1992 Jun 15;52(12):3372-7 [1596895.001]
  • [Cites] Science. 1994 Mar 4;263(5151):1281-4 [8122112.001]
  • [Cites] J Biol Chem. 1994 Dec 9;269(49):30994-8 [7527039.001]
  • [Cites] Cancer Res. 1995 Apr 15;55(8):1625-8 [7712464.001]
  • [Cites] Nucleic Acids Res. 1995 Oct 11;23(19):3974-9 [7479045.001]
  • [Cites] Blood. 2002 Oct 15;100(8):2717-23 [12351377.001]
  • [Cites] Oncogene. 2006 Jul 20;25(31):4376-80 [16501600.001]
  • [Cites] J Cell Biol. 2008 Jul 14;182(1):19-26 [18625840.001]
  • [Cites] Leukemia. 2008 Nov;22(11):2041-7 [18668134.001]
  • [Cites] Leukemia. 2009 Feb;23(2):262-70 [19020547.001]
  • [Cites] Nucleic Acids Res. 1998 Oct 1;26(19):4508-15 [9742256.001]
  • [Cites] Blood. 1998 Oct 1;92(7):2322-33 [9746770.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3706-11 [10097101.001]
  • [Cites] Protein Sci. 1999 Apr;8(4):905-12 [10211837.001]
  • [Cites] Prostate. 1999 Jun 1;39(4):298-304 [10344220.001]
  • [Cites] N Engl J Med. 2005 Jan 20;352(3):254-66 [15659725.001]
  • [Cites] J Biol Chem. 2005 Mar 25;280(12):10988-96 [15644315.001]
  • [Cites] Biochem J. 2005 May 15;388(Pt 1):7-15 [15737070.001]
  • [Cites] Blood. 2005 Aug 1;106(3):899-902 [15831697.001]
  • [Cites] Nat Cell Biol. 2005 Aug;7(8):823-30 [16041368.001]
  • [Cites] Blood. 2005 Aug 15;106(4):1419-22 [15870172.001]
  • [Cites] Mol Cell Biol. 2005 Sep;25(17):7534-45 [16107701.001]
  • [Cites] Nature. 2005 Sep 1;437(7055):147-53 [16007073.001]
  • [Cites] Mol Cell Biol. 2005 Oct;25(20):8874-86 [16199867.001]
  • [Cites] Blood. 2005 Oct 15;106(8):2854-61 [15994285.001]
  • [Cites] Blood. 2005 Nov 15;106(10):3618-20 [16046528.001]
  • [Cites] Blood. 2005 Dec 1;106(12):3740-6 [16051734.001]
  • [Cites] Blood. 2005 Dec 1;106(12):3733-9 [16076867.001]
  • [Cites] Blood. 2005 Dec 1;106(12):3747-54 [16109776.001]
  • [Cites] Cell Cycle. 2005 Nov;4(11):1593-8 [16205118.001]
  • [Cites] Cancer Res. 2006 Mar 15;66(6):3044-50 [16540653.001]
  • [Cites] Cancer Res. 2006 Mar 15;66(6):3310-6 [16540685.001]
  • [Cites] Mol Cell Biol. 2006 May;26(10):3798-809 [16648475.001]
  • [Cites] Blood. 2006 May 15;107(10):4011-20 [16455956.001]
  • [Cites] Br J Haematol. 2006 Jun;133(6):638-41 [16704439.001]
  • [Cites] Blood. 2006 Jun 1;107(11):4514-23 [16455950.001]
  • [Cites] Leukemia. 2006 Jun;20(6):1103-8 [16541144.001]
  • [Cites] Nat Rev Cancer. 2006 Jul;6(7):493-505 [16794633.001]
  • [Cites] Haematologica. 2006 Aug;91(8):1147-8 [16870548.001]
  • [Cites] Blood. 2006 Sep 15;108(6):1999-2005 [16720834.001]
  • [Cites] Leuk Res. 2007 Jan;31(1):109-11 [16678898.001]
  • [Cites] Trends Mol Med. 2006 Dec;12(12):580-7 [17071139.001]
  • [Cites] Nature. 2006 Nov 30;444(7119):638-42 [17136094.001]
  • [Cites] Blood. 2006 Dec 15;108(13):4146-55 [16926285.001]
  • [Cites] Blood. 2007 Feb 1;109(3):874-85 [17008539.001]
  • [Cites] Leukemia. 2007 Feb;21(2):366-7 [17151698.001]
  • [Cites] Leuk Res. 2007 Apr;31(4):427-34 [17161457.001]
  • [Cites] Leukemia. 2007 May;21(5):1099-103 [17301808.001]
  • [Cites] Leukemia. 2007 May;21(5):998-1004 [17361227.001]
  • [Cites] APMIS. 2007 Apr;115(4):341-6 [17504301.001]
  • [Cites] Leukemia. 2007 Jun;21(6):1307 [17315018.001]
  • (PMID = 19569254.001).
  • [ISSN] 1099-1069
  • [Journal-full-title] Hematological oncology
  • [ISO-abbreviation] Hematol Oncol
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA111728-05; United States / NCI NIH HHS / CA / K23 CA111728; United States / NCI NIH HHS / CA / T32 CA060441; United States / NCI NIH HHS / CA / K23 CA111728-05
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Nuclear Proteins; 117896-08-9 / nucleophosmin
  • [Number-of-references] 102
  • [Other-IDs] NLM/ NIHMS234930; NLM/ PMC3069851
  •  go-up   go-down


88. Chung BJ, Akst LM, Koltai PJ: 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol; 2006 Nov;70(11):1911-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis.
  • OBJECTIVES: Intralesional injection of cidofovir has been described as an adjunctive treatment for pediatric recurrent respiratory papillomatosis (RRP).
  • METHODS: Eleven pediatric patients originally treated with a standardized stepped-dose protocol of intralesional cidofovir for RRP were followed for an extended observational period.
  • Two patients initially achieved remission but have subsequently required additional treatment for recurrent disease.

  • Genetic Alliance. consumer health - Recurrent respiratory papillomatosis.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CIDOFOVIR .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16919339.001).
  • [ISSN] 0165-5876
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Organophosphonates; 8J337D1HZY / Cytosine; JIL713Q00N / cidofovir
  •  go-up   go-down


89. Metzger ML, Hudson MM, Krasin MJ, Wu J, Kaste SC, Kun LE, Sandlund JT, Howard SC: Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients. Cancer; 2010 Sep 15;116(18):4376-84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients.
  • BACKGROUND: Pediatric Hodgkin lymphoma (HL) is a highly curable disease; however, prognostic factors for the survival of patients who develop recurrent disease have not been clearly defined.
  • METHODS: This was a retrospective analysis of 50 pediatric patients with HL who relapsed or progressed between 1990 and 2006 and who were retrieved with intense cytoreductive treatment regimens followed by autologous stem cell transplantation and radiation therapy.
  • Fifteen patients developed progressive disease during therapy, 14 patients relapsed early, and 21 patients relapsed late.
  • CONCLUSIONS: The current results indicated that pediatric patients with relapsed HL who have an inadequate response after initial primary salvage chemotherapy have a very poor prognosis and should be considered for novel therapies directed at biologic or immunologic targets.

  • Genetic Alliance. consumer health - Hodgkin lymphoma.
  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 American Cancer Society.
  • [Cites] J Clin Oncol. 1993 Apr;11(4):704-11 [8478664.001]
  • [Cites] Blood. 1993 Mar 1;81(5):1137-45 [8443375.001]
  • [Cites] Radiology. 1997 Jun;203(3):795-800 [9169707.001]
  • [Cites] Radiology. 1998 Feb;206(2):475-81 [9457202.001]
  • [Cites] Ann Oncol. 1998 Mar;9(3):289-95 [9602263.001]
  • [Cites] Bone Marrow Transplant. 1998 Aug;22(3):265-71 [9720740.001]
  • [Cites] N Engl J Med. 1998 Nov 19;339(21):1506-14 [9819449.001]
  • [Cites] J Clin Oncol. 1999 Oct;17(10):3101-9 [10506605.001]
  • [Cites] J Clin Oncol. 2004 Nov 15;22(22):4532-40 [15542804.001]
  • [Cites] J Clin Oncol. 2004 Nov 15;22(22):4541-50 [15542805.001]
  • [Cites] J Pediatr Hematol Oncol. 2004 Nov;26(11):740-5 [15543009.001]
  • [Cites] Br J Haematol. 2005 Aug;130(3):363-72 [16042685.001]
  • [Cites] J Clin Oncol. 2005 Sep 1;23(25):6181-9 [16135485.001]
  • [Cites] Blood. 2006 Jan 1;107(1):52-9 [16150944.001]
  • [Cites] Haematologica. 2006 Apr;91(4):475-81 [16585014.001]
  • [Cites] Haematologica. 2006 Apr;91(4):482-9 [16585015.001]
  • [Cites] Am J Clin Oncol. 2006 Apr;29(2):189-95 [16601441.001]
  • [Cites] Ann Hematol. 2006 Nov;85(11):759-67 [16871391.001]
  • [Cites] Biol Blood Marrow Transplant. 2006 Oct;12(10):1065-72 [17084370.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2007 Jan;34(1):60-7 [17021808.001]
  • [Cites] Radiology. 2007 Jul;244(1):257-62 [17581905.001]
  • [Cites] Semin Radiat Oncol. 2007 Jul;17(3):230-42 [17591570.001]
  • [Cites] Blood. 2000 Aug 15;96(4):1280-6 [10942369.001]
  • [Cites] Blood. 2001 Jan 15;97(2):404-9 [11154216.001]
  • [Cites] J Clin Oncol. 2002 Jan 1;20(1):221-30 [11773173.001]
  • [Cites] J Clin Oncol. 2002 Feb 1;20(3):630-7 [11821442.001]
  • [Cites] Ann Oncol. 2002;13 Suppl 1:112-6 [12078891.001]
  • [Cites] Lancet. 2002 Jun 15;359(9323):2065-71 [12086759.001]
  • [Cites] J Clin Oncol. 2002 Jul 15;20(14):3081-7 [12118021.001]
  • [Cites] J Clin Oncol. 2003 May 15;21(10):2026-33 [12743158.001]
  • [Cites] Cancer Res. 1971 Nov;31(11):1860-1 [5121694.001]
  • [Cites] Br J Haematol. 1992 Jun;81(2):197-202 [1643017.001]
  • [Cites] J Clin Oncol. 1993 Jan;11(1):100-8 [8418221.001]
  • [Cites] J Clin Oncol. 1993 Dec;11(12):2351-61 [8246024.001]
  • (PMID = 20564743.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA-78224; United States / NIGMS NIH HHS / GM / U01 GM061393; United States / NCI NIH HHS / CA / R37 CA036401-24; United States / NCI NIH HHS / CA / CA-60419; None / None / / P30 CA021765-31; United States / NCI NIH HHS / CA / CA078224-10; United States / NCI NIH HHS / CA / R01 CA078224; United States / NCI NIH HHS / CA / R37 CA036401; None / None / / R01 CA051001-15; United States / NCI NIH HHS / CA / CA-36401; United States / NIGMS NIH HHS / GM / GM061393-100007; United States / NCI NIH HHS / CA / R01 CA060419; United States / NCI NIH HHS / CA / CA-51001; United States / NCI NIH HHS / CA / CA036401-24; United States / NCI NIH HHS / CA / CA-21765; United States / NCI NIH HHS / CA / R01 CA051001-15; United States / NCI NIH HHS / CA / P30 CA021765; United States / NCI NIH HHS / CA / R01 CA078224-10; United States / NCI NIH HHS / CA / P30 CA021765-31; United States / NCI NIH HHS / CA / R01 CA051001; United States / NCI NIH HHS / CA / R01 CA036401; United States / NIGMS NIH HHS / GM / U01 GM061393-100007; United States / NIGMS NIH HHS / GM / GM-61393; United States / NCI NIH HHS / CA / U01 CA060419
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS189726; NLM/ PMC2936658
  •  go-up   go-down


90. Kuiper RP, Waanders E, van der Velden VH, van Reijmersdal SV, Venkatachalam R, Scheijen B, Sonneveld E, van Dongen JJ, Veerman AJ, van Leeuwen FN, van Kessel AG, Hoogerbrugge PM: IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia; 2010 Jul;24(7):1258-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.
  • Relapse is the most common cause of treatment failure in pediatric acute lymphoblastic leukemia (ALL) and is often difficult to predict.
  • To explore the prognostic impact of recurrent DNA copy number abnormalities on relapse, we performed high-resolution genomic profiling of 34 paired diagnosis and relapse ALL samples.
  • Recurrent lesions detected at diagnosis, including PAX5, CDKN2A and EBF1, were frequently absent at relapse, indicating that they represent secondary events that may be absent in the relapse-prone therapy-resistant progenitor cell.
  • A targeted copy number screen in an unselected cohort of 131 precursor B-ALL cases, enrolled in the dexamethasone-based Dutch Childhood Oncology Group treatment protocol ALL9, revealed that IKZF1 deletions are significantly associated with poor relapse-free and overall survival rates.
  • [MeSH-major] Gene Deletion. Ikaros Transcription Factor / genetics. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / genetics. Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis. Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics


91. Huang A, Abbasakoor F, Vaizey CJ: Gastrointestinal manifestations of chronic granulomatous disease. Colorectal Dis; 2006 Oct;8(8):637-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Chronic granulomatous disease is a rare clinical entity characterized by recurrent infective and inflammatory complications.
  • A history of recurrent infections during childhood is common.

  • Genetic Alliance. consumer health - Chronic Granulomatous Disease.
  • MedlinePlus Health Information. consumer health - Bacterial Infections.
  • MedlinePlus Health Information. consumer health - Gastroenteritis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16970572.001).
  • [ISSN] 1462-8910
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 41
  •  go-up   go-down


92. Won SC, Han JW, Kwon SY, Shin HY, Ahn HS, Hwang TJ, Yang WI, Lyu CJ: Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: A report from the Korean society of pediatric hematology-oncology. Ann Hematol; 2006 Nov;85(11):787-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: A report from the Korean society of pediatric hematology-oncology.
  • Recent development of stratified chemotherapeutic regimens has rapidly improved the survival rate of non-Hodgkin's lymphoma (NHL) of childhood.
  • Despite these improvements, the outcome for children with recurrent or refractory NHL remains dismal.
  • We explored the use of high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (HDC/PBSCT) for children with either refractory or recurrent NHL, and we evaluated various factors influencing outcome of HDC/PBSCT.
  • All patients had refractory or recurrent NHL.
  • Sex, stage at diagnosis, histologic subtype (lymphoblastic, Burkitt's, and large-cell lymphoma), LDH level at diagnosis, disease status at transplantation, and preparative regimens for HDC/PBSCT were explored.
  • In regard to the patients, six had Burkitt's lymphoma, 13 had lymphoblastic lymphoma, and 14 had large-cell lymphoma.
  • The EFS for Burkitt's, lymphoblastic, and large-cell lymphoma was 66.7+/-27.2, 50.5+/-14.8, and 82.1+/-11.7%, respectively.
  • In comparison with lymphoblastic and non-lymphoblastic lymphoma, the relative risk for lymphoblastic lymphoma was higher than the others (P = 0.037).
  • HDC/PBSCT is considered applicable to recurrent or refractory pediatric NHL patients safely and it could replace conventional chemotherapy.
  • However, refractory or recurrent lymphoblastic lymphoma patients showed dismal results.

  • Genetic Alliance. consumer health - Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Ann Hematol. 2007 Apr;86(4):309
  • (PMID = 16932891.001).
  • [ISSN] 0939-5555
  • [Journal-full-title] Annals of hematology
  • [ISO-abbreviation] Ann. Hematol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


93. Lo SS, Chang EL, Sloan AE: Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy in the management of intracranial ependymoma. Expert Rev Neurother; 2006 Apr;6(4):501-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ependymoma accounts for 5-10% of all childhood CNS tumors and less than 5% of intracranial tumors in adults.
  • SRS has been used in recurrent disease and as a boost after external beam radiation therapy.
  • FSRT has been used in pediatric brain tumors and can potentially limit the long-term toxicities associated with radiation therapy by reducing the amount of normal brain parenchyma treated.

  • Genetic Alliance. consumer health - Ependymoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16623649.001).
  • [ISSN] 1744-8360
  • [Journal-full-title] Expert review of neurotherapeutics
  • [ISO-abbreviation] Expert Rev Neurother
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 29
  •  go-up   go-down


94. McMillan HJ, Yang M, Jones HR: Brachial plexopathy and nonaccidental injury: role of the neurologist. J Child Neurol; 2010 May;25(5):620-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report a toddler who presented with a recurrent brachial plexopathy due to nonaccidental injury.
  • [MeSH-minor] Arm Injuries / complications. Arm Injuries / diagnosis. Diagnosis, Differential. Female. Fractures, Bone / complications. Fractures, Bone / diagnosis. Humans. Infant. Lead Poisoning, Nervous System, Childhood / complications. Lead Poisoning, Nervous System, Childhood / diagnosis. Parents. Recurrence

  • MedlinePlus Health Information. consumer health - Brachial Plexus Injuries.
  • MedlinePlus Health Information. consumer health - Children's Health.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20413805.001).
  • [ISSN] 1708-8283
  • [Journal-full-title] Journal of child neurology
  • [ISO-abbreviation] J. Child Neurol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


95. Germain DP: Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis; 2007 Jul 19;2:32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There is a high risk of recurrent colonic perforations.
  • In childhood, coagulation disorders and Silverman's syndrome are the main differential diagnoses; in adulthood, the differential diagnosis includes other Ehlers-Danlos syndromes, Marfan syndrome and Loeys-Dietz syndrome.


96. Garat JM, Angerri O, Caffaratti J, Moscatiello P, Villavicencio H: Primary congenital bladder diverticula in children. Urology; 2007 Nov;70(5):984-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: To present the symptoms, treatment, evolution, and pathologic findings of primary (nonobstructive) diverticula in childhood.
  • Primary (nonobstructive) diverticula are not frequent in childhood.
  • The main reason for consultation was febrile urinary infection (n = 5), recurrent urinary infections (n = 3), enuretic syndrome (n = 1), gross hematuria (n = 1), and pain in the right iliac fossa (n = 1).

  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18068458.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Fietta P: Behçet's disease: familial clustering and immunogenetics. Clin Exp Rheumatol; 2005 Jul-Aug;23(4 Suppl 38):S96-105
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Behçet's disease (BD) is a relapsing, multisystemic inflammatory disorder, characterized by major symptoms consisting of recurrent orogenital ulcerations, eye and skin lesions.
  • The BD familial aggregation is characterized by both genetic anticipation and higher prevalence in childhood patients, likely defining a subset with stronger immunogenetic influences.

  • Genetic Alliance. consumer health - Behcet's Disease.
  • MedlinePlus Health Information. consumer health - Behcet's Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16273774.001).
  • [ISSN] 0392-856X
  • [Journal-full-title] Clinical and experimental rheumatology
  • [ISO-abbreviation] Clin. Exp. Rheumatol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 181
  •  go-up   go-down


98. Buitendijk S, van de Ven CP, Dumans TG, den Hollander JC, Nowak PJ, Tissing WJ, Pieters R, van den Heuvel-Eibrink MM: Pediatric aggressive fibromatosis: a retrospective analysis of 13 patients and review of literature. Cancer; 2005 Sep 1;104(5):1090-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pediatric aggressive fibromatosis: a retrospective analysis of 13 patients and review of literature.
  • BACKGROUND: Aggressive fibromatosis (AF) is a soft tissue tumor and is rare in childhood, with high potential for local invasiveness and recurrence.
  • General recommendations for the clinical management of pediatric patients with AF remain undetermined.
  • METHODS: The authors retrospectively analyzed 13 children with AF who were diagnosed from 1987 until 2004 in the Erasmus MC-Sophia Children's Hospital, and a review of the pediatric literature was conducted.
  • Three patients developed recurrent AF, including two recurrences after patients underwent incomplete resection without adjuvant treatment.
  • Ten pediatric AF studies, including the current study, with a total of 187 patients were reviewed.
  • Multicenter, prospective (randomized) trials will be necessary to clarify the role of adjuvant treatment for patients with pediatric AF.


99. Villalon-Lopez JS, Valle-Mejia CA, Patino-Lara A, Moreno-Perez BA, Munoz-Lopez JA, Alcantar-Andrade A: Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review. J Cancer Res Ther; 2006 Jul-Sep;2(3):140-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Basal cell carcinoma (BCC) is the most frequent type of skin cancer in humans, with cumulative exposure to ultraviolet radiation as an important risk factor for development of illness such as severe solar burns during childhood or adolescence.
  • The case of a 77-year-old patient is presented with BCC of inferior eyelid of 14 years' duration, formerly managed with radiotherapy; however, due to recurrent illness and invasion to the maxillary antrum, he needed supraestructure maxillectomy with left orbital exenteration.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17998694.001).
  • [ISSN] 1998-4138
  • [Journal-full-title] Journal of cancer research and therapeutics
  • [ISO-abbreviation] J Cancer Res Ther
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


100. Majorana A, Bardellini E, Flocchini P, Amadori F, Conti G, Campus G: Oral mucosal lesions in children from 0 to 12 years old: ten years' experience. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul;110(1):e13-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The exact prevalence of oral lesions in childhood is not well known.
  • The most frequent lesions recorded were oral candidiasis (28.4%), geographic tongue and other tongue lesions (18.5%), traumatic lesions (17.8%), recurrent aphthous ulcerations (14.8%), herpes simplex virus type 1 infections (9.3%), and erythema multiforme (0.9%).

  • Genetic Alliance. consumer health - TEN.
  • MedlinePlus Health Information. consumer health - Mouth Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Mosby, Inc. All rights reserved.
  • [CommentIn] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Dec;110(6):684; author reply 684 [21112528.001]
  • (PMID = 20452255.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement